University of Arkansas, Fayetteville

ScholarWorks@UARK
Graduate Theses and Dissertations
12-2017

Experimental Approaches to Understand and Control Salmonella
Infection in Poultry
Yichao Yang
University of Arkansas, Fayetteville

Follow this and additional works at: https://scholarworks.uark.edu/etd
Part of the Food Biotechnology Commons, Food Microbiology Commons, Food Processing Commons,
Pathogenic Microbiology Commons, and the Poultry or Avian Science Commons

Citation
Yang, Y. (2017). Experimental Approaches to Understand and Control Salmonella Infection in Poultry.
Graduate Theses and Dissertations Retrieved from https://scholarworks.uark.edu/etd/2602

This Dissertation is brought to you for free and open access by ScholarWorks@UARK. It has been accepted for
inclusion in Graduate Theses and Dissertations by an authorized administrator of ScholarWorks@UARK. For more
information, please contact scholar@uark.edu.

Experimental Approaches to Understand and Control Salmonella Infection in Poultry

A dissertation submitted in partial fulfillment
of the requirements for the degree of
Doctor of Philosophy in Poultry Science

by

Yichao Yang
Northeast Agricultural University in China
Bachelor of Science in Veterinary Medicine, 2010

December 2017
University of Arkansas

This dissertation is approved for recommendation to the Graduate Council.

_______________________________

Dr. Young Min Kwon
Dissertation Director
_______________________________

______________________________

Dr. Billy M. Hargis
Committee Member

Dr. Steven C. Ricke
Committee Member

_______________________________

Dr. Ravi Barabote
Committee Member

ABSTRACT
Salmonella is a major foodborne pathogen around the world and chickens are the major
reservoir to transmit Salmonella into the human food chain. For decreasing the infection of
Salmonella, we developed six attenuated live vaccines based on Salmonella Enteritidis (SE) and
Typhimurium (ST) for testing the cross-serovar and cross-serogroup protection from the challenge
of Salmonella Heidelberg and Campylobacter jejuni. One of the constructed vaccine strain showed
ability to protect against challenge from Salmonella Heidelberg. Even though some preventive
approaches are able to decrease Salmonella colonization in the gastrointestinal tract of chickens or
other farm animals, Salmonella transmission mechanisms remain unclear. For analyzing
Salmonella transmission routes and dynamics, we designed a series of Salmonella isogenic
barcode-tagged strains by inserting six random nucleotides into a functionally neutral region on
the chromosome of Salmonella Enteritidis. These barcode-tagged strains can be used as a tool for
quantitative tracking of Salmonella transmission in the chicken flock by profiling the barcode
regions using high-throughput sequencing. The efficiency of this novel approach has been
estimated by chicken experiments and can be applied for further studies about Salmonella
transmission and population dynamics. Due to the increasing pressure of using antibiotics as the
growth promoter in the farm animals, probiotics is a suitable alternative to replace antibiotics by
providing beneficial effects, such as promotion of animal health, decreased infection by pathogens,
and improval of growth performance in poultry. In this study, 90 probiotic candidate strains were
isolated and evaluated for decreasing the gut permeability in Caco-2 cell lines. The result from
animal experiments indicated that a combined batch culture of 3 selected strains showed significant
efficacy in controlling intestinal colonization of ST in neonatal turkey poults.
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CHAPTER ONE
1.1 Introduction
1.1.1 Development of Salmonella-based Vaccines
For controlling the infection of Salmonella, many kinds of vaccines have been applied in farm
animals and humans. Killed whole-cell Salmonella vaccines have been studied and applied over
the last century (Collins, 1974; Eisenstein et al., 1984b). However, whole-cell killed Salmonella
vaccines confer partial protection against intestinal colonization, fecal shedding, and egg
contamination in chickens (Mastroeni et al., 2001). Even though the protection of whole-cell killed
vaccines in chickens was greatly improved by adding strong adjuvants, such as oil emulsions, it
still provides less protection than live vaccines (Gast et al., 1992; Barbour et al., 1993). This is
probably due to the fact that killed vaccines are able to induce humoral responses, but have a poor
ability to induce cell-mediated immunity in the vaccinated animals (Collins, 1974; Bairey, 1978;
Aitken et al., 1982). Besides killed vaccines, Salmonella bacterial fractions such as detoxified
lipopolysaccharide (LPS), outer membrane proteins (OMPs), and O-polysaccharides also have
been shown to elicit high antibody responses and induce moderate protection (Ding et al., 1990;
Anderson et al., 1991; Meenakshi et al., 1999; Watson et al., 1992; Konadu et al., 2000). Although
these inactivated and subunit vaccines are able to elicit high antibody responses, prevent shedding
in chickens, and confer some degree of protection against Salmonella challenge, there are several
live attenuated vaccines that are potentially superior for controlling Salmonella in animals and
human.
For developing the live attenuated Salmonella vaccines, it is critical to choose the target genes
for making deletion mutation for virulence attenuation. Attenuation should produce Salmonella
with reduced ability to grow and survive in the host. Genetic inactivation of too many critical genes
1

or inappropriate selection of target genes results in failing to colonize in the host and to induce
innate or acquired immunity, and finally failing to produce durable protection for the vaccinated
subjects (Dilts et al., 2000; Levine et al., 1987; Hohmann et al., 1996). The successful attenuated
vaccines that perform well in clinical trials is targeting both mutation of metabolic pathways and
virulence determinants (Galen and Curtiss, 2014). When the strategies for attenuation are
confirmed by targeting virulence and metabolism, the balance between the safety and
immunogenicity should be considered. The reason is that the over-attenuation of metabolic genes
may weaken the metabolic fitness of the vaccine strain, resulting in decrease of immunogenicity.
In our project, two genes, aroA and htrA, were deleted for making the attenuated vaccine strain.
The gene aroA is involved in aromatic amino acid synthesis and biosynthesis of paraaminobenzoic acid (PABA) and 2, 3-dihydrobenzoate (DHB) (Hoiseth and Stocker, 1981).
Multiple studies have shown that Salmonella aroA mutants are able to produce robust immune
responses and then protect animals against lethal challenge (Eisenstein et al., 1984a; Harrison et
al., 1997; Killar and Eisenstein, 1985). The gene htrA encodes a serine protease that is related to
the protection against heat stress and oxidative stress (Pallen and Wren, 1997). Research on
Salmonella ΔhtrA mutants indicated decreased survival within macrophages, decreased virulence
in mice, but increased protection for the challenge from Salmonella Typhimurium (Baumler et al.,
1994; Johnson et al., 1991; Pickett et al., 2000). The mutant strain with double deletions of aroA
and htrA genes confer protection against the oral challenge with virulent Salmonella by single dose
vaccination (Chatfield et al., 1992). These two deletion mutants have been established to be safe
in humans and be able to induce anti-flagellar antibodies, as well as cell-mediated responses to
particular antigens (Lowe et al., 1999; Tacket et al., 1992).
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The live Salmonella attenuated vaccine strain is not only used to provide protection from the
challenge of Salmonella, it is also applicable for delivering heterologous antigens and constructing
multivalent vaccines. The attenuated Salmonella vaccine strain can be used as a vector to express
heterologous antigens from other pathogens, can be delivered into mucosal surfaces for eliciting
strong local and systemic immune responses, and finally can provide protection against Salmonella
as well as other pathogens that are derived from heterologous antigens (Roberts, 1994; Hormaeche,
1995). The efficacy of multivalent attenuated Salmonella vaccines requires the sustained
expression of heterologous antigens in an immunogenic form and at a sufficient level to induce
the strong and lasting immune responses. For achieving these goals, some of the common problems
should be solved, such as plasmid instability, toxicity of the foreign antigens for the bacterial host,
and incorrect folding of the expressed epitopes (Mastroeni et al., 2001). In this project, the
heterologous genes were integrated into the lamB region in the Salmonella chromosome, resulting
in the stabilized expression of the foreign antigens. Briefly, the I-SceI and kanamycin cassette was
introduced in the genome of Salmonella expressing the Red Recombinase enzymes. Next, this
sequence was replaced by the joined DNA fragments, a section of Campylobacter Omp18 protein
(Cj0113), peptidoglycan associated lipoprotein of Salmonella (PAL) and a portion of chicken high
mobility group box 1 protein (HGMB1). DNA fragments used for homologous recombination
were linear PCR products which consisted of the foreign insertion sequence flanked by
homologous sequences of the up-stream and down-stream of lamB gene of Salmonella encoding
outer membrane protein.

3

1.1.2 Analysis of Salmonella Transmission Mechanism

Salmonella is a major foodborne pathogen causing approximately one million foodborne
illnesses in the US every year (CDC). Chickens play an important role for transmitting Salmonella
into the human food chain. Even though many approaches have been developed to reduce
Salmonella colonization in the chicken gastrointestinal tract, the fundamental understanding of
Salmonella transmission routes and mechanism within the chicken flock remain unclear. During
the past decades, several researchers studied Salmonella transmission mechanisms by constructing
the marker strains that are antibiotic-resistant or expressing fluorescence genes. These marker
strains can be differentiated from the wild-type strains when administered into the chickens for
analyzing Salmonella transmission mechanisms. However, there is a possibility that the phenotype
may be altered in the marker strains, resulting in a change of behavior from the corresponding wild
type strains. For analyzing Salmonella transmission dynamics within the chicken flock, it is
necessary to construct the marker strains that perform in the same manner as the wild-type strains
when used for quantitatively tracking within the chicken and environment. In this project, a series
of isogenic barcode-tagged strains were constructed by inserting six random nucleotides into a
functionally neutral region in the chromosome of Salmonella Enteritidis as a tool for quantitative
tracking of Salmonella transmission within a chicken flock. These Salmonella isogenic barcodetagged strains can be administered in different dose levels at the same time through different routes,
which are powerful for analyzing Salmonella transmission routes, infection dose levels, and
competition between different strains.

4

1.1.3 Isolation and Evaluation of Probiotic Candidate Strains for Reducing Gut Permeability and
Decreasing Salmonella Typhimurium Colonization

Due to the increasing pressure against the use of antibiotics as a growth promoter in recent
years, there is an increasing demand for seeking alternative products to promote animal health,
decrease the infection from pathogens, and improve growth performance in the poultry industry.
Probiotics are able to provide beneficial effects on the host when orally administered. The benefits
of probiotics have been demonstrated in farm animals and humans by many studies, and therefore
probiotics have attracted the interest of the poultry industry and can be used as an alternative to
antibiotic growth promoters (Dicks and Botes, 2010). However, the mechanism of these beneficial
effects on the hosts remain elusive and appear diverse for different probiotic strains. Therefore,
appropriate method is lacking to select effective probiotic strains aiming at different effects on the
host. To elucidate this problem, we developed a novel approach to screen a large number of
probiotic strains isolated from healthy chicken guts for identifying the probiotic candidate strains
with the capability of enhancing the gut barrier functions.
Probiotic strains play an important role in maintaining the gut health and reducing pathogens
in poultry. The interaction between the probiotic strains population and gut epithelial cells is also
crucial for the gut health. The gut mucosal epithelial cell lining are able to maintain a defensive
barrier for controlling the pathogen invasion, as well as allowing the nutrient absorption (Rao and
Samak, 2013). Any damage of the mucosal epithelial cell lines is correlated with the decrease of
barrier function, which allows translocation of pathogens from the intestinal lumen into the blood
stream (Song et al., 2014; Ulluwishewa et al., 2011). The single layer of epithelial cells are joined
together by tight junction proteins and form the gut barrier. Many studies have demonstrated that
the disorder of epithelial cell lining are related to multiple diseases, such as inflammatory bowel
5

disease (IBD) and food allergies (Ulluwishewa et al., 2011; Miyauchi et al., 2012). The tight
junction proteins are multi-protein complexes and are used for sealing the paracellular space
between adjacent epithelial cells and limiting the transportation of pathogens (Miyauchi et al.,
2012). Transepithelial electrical resistance (TEER) can be used as the measurement of the
intestinal barrier integrity. Some conditions including heat stress and feed restriction have been
shown to increase the gut permeability, which is ameliorated by administration of probiotic strains
(Song et al., 2014; Vicuna et al., 2015). In this project, we developed a novel approach for
screening functional probiotic strains targeting improving the gut integrity and evaluated the
efficacy of probiotic candidate strains in turkey poults by using the therapeutic model of
Salmonella colonization.
1.2 Objectives
The objectives of my research in this dissertation were to develop recombinant Salmonella
vaccines to provide cross-serovar and cross-serogroup protection, to analyze Salmonella
transmission mechanisms within the chicken flock, and to identify and evaluate probiotic candidate
strains for reducing gut permeability and decreasing Salmonella Typhimurium colonization in
turkey poults.
Specific objectives for this dissertation are as follows:
1. To develop recombinant Salmonella vaccines against the challenge from Salmonella
Heidelberg for testing of cross-serogroup protection with S. Enteritidis vectored vaccine
candidates.
2. To quantitative track of Salmonella transmission routes using barcode-tagged isogenic
strains in chickens.
3. To study the theory of Salmonella competitive exclusion by using barcode-tagged isogenic
strains.
6

4. To isolate and evaluate lactic acid bacteria candidates for intestinal epithelial permeability
reduction and Salmonella Typhimurium colonization in neonatal turkey poults.
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2.1 Abstract
Historically, Salmonella vaccines have been either live attenuated or killed bacterin
vaccines that fail to offer cross-protection against other serogroups, which limits true risk
mitigation and protection of consumers. Subunit recombinant vaccines which possess highly
conserved antigens offer potential to provide cross-serogroup protection, and ability to express
immune-enhancing molecules that promote uptake and recognition by the immune system. Six
Salmonella subunit vaccine candidates were developed in either attenuated S. Enteritidis (SE) or
S. Typhimurium (ST) that on the cell surface expresses antigenic epitopes of high mobility group
box 1 immune-enhancing sequence (H), peptidoglycan associated lipoprotein (P), and Omp18
protein Cj0113 (C) in different pattern arrangements for evaluation against S. Heidelberg (SH)
challenge in broilers. In exp. 1, chicks were orally vaccinated with SE-CPH, SE-HCP, SE-CHP,
ST-CPH, ST-HCP, or ST-CHP at 1x107 CFU/chick, or saline control on d1 and d14. On d17 all
birds were challenged with 6x106 cfu/chick SH, and ceca collected on d23 and d28. On d23 only
SE-CPH reduced (P<0.05) SH recovery at 0.34±0.23 log10 CFU when compared to control at
1.19±0.26 log10 CFU. On d28, SE-CPH and ST-HCP reduced SH recovery at 0.40±0.40 and
0.51±0.26 log10 CFU, respectively in comparison to control at 1.36±0.23 log10 CFU. For exp. 2,
chicks were orally vaccinated with 1x108 CFU/chick SE-CPH, SE-HCP, SE-CHP or saline on d1.
At d7 all chicks were orally challenged with 7x106 CFU/chick SH and ceca collected on d28 and
d35. Only SE-CPH reduced (P<0.05) SH recovery on d28 when compared to control (6.16±0.13
vs. 4.71±0.55 log10 CFU). In exp 3, chicks were vaccinated by spray in a commercial vaccination
cabinet with SE-CPH vaccination, 1.6x107 CFU/chick, or saline control. Birds were challenged on
d14 with 3x107 CFU/chick SH and ceca collected on d18 and d25. SE-CPH reduced SH recovery
(P<0.05) on d18, 2.75±0.05 log10 CFU, and d25, 1.89±0.43 log10 CFU, as compared to control
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chickens at 5.6±0.37 (d18) and 3.98±0.5 log10 cfu (d25). The results of these experiments suggest
that cross-serogroup protection is possible using these SE and ST vectored subunit vaccines.
2.2 Introduction
Cases of salmonellosis are most commonly linked to contaminated eggs and poultry
products, which are the leading source of Salmonella outbreaks in the United States and Europe.
In addition, Campylobacter continues to be a food safety concern with over 18 million annual
cases of gastroenteritis associated with the pathogen in the United States (Kaakoush et al., 2015).
As a result, the poultry industry has sought multiple ante mortem intervention strategies that
include increased biosecurity, therapeutic antibiotics, competitive exclusion and probiotics, and
vaccination. The two most common types of vaccines used in animal agriculture are killed wholecell bacterins and live attenuated vaccines, both of which are useful in many applications, but do
have limitations (Barrow, 2007). Killed vaccines have been primarily used to protect against
systemic infections, and although they have been known to reduce colonization and shedding, the
protection provided by these vaccines has only limited ability to stop mucosal colonization
(Deguchi et al., 2009; Nakamura et al., 2004). Additionally, they often require injection, which is
not practical in the poultry industry due to the large number of animals that would require
vaccination.
Live attenuated vaccines have ability to colonize the gut which may provide a mucosal
immune response, as well as potentially competitively exclude heterologous strains of Salmonella
from colonizing the GIT (Barrow, 2007; Holt and Gast, 2004; Van Immerseel et al., 2005). The
adaptive immune response elicited by live vaccines is composed of a humoral as well as cellmediated response similar to that seen in a natural infection (Barrow, 2007; Mastroeni et al., 2001;
Van Immerseel et al., 2005). This is in contrast to a killed vaccine, which primarily stimulates a
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humoral response. After vaccination, protection against homologous strains of Salmonella is
almost complete (Chacana and Terzolo, 2006; Ghany et al., 2007), but often little protection is
afforded against a challenge by a heterologous serotype (Barrow, 2007; Young et al., 2007). Thus
cross-serotype protection, especially against minor serovars for which live attenuated vaccines are
not available, has become a desirable aspect of Salmonella vaccines.
Subunit vaccines, genetically modified bacteria, containing antigens against multiple
pathogens, including attenuated live recombinant bacterial vectored vaccines have become viable
options for animal agriculture vaccines as a result of recent advances in the field. Many research
programs have modified multiple species of bacteria including Salmonella Typhimurium,
Salmonella Enteritidis, Salmonella Typhi, Escherichia coli, Lactobacillus casei, Lactobacillus
reuteri, Bacillus subtilis, and Bacillus thuringiensis, to name a few, to express protein antigens
against bacterial, viral, and protozoal pathogens as well as toxins (Arnold et al., 2004; Deguchi et
al., 2009; Duc and Cutting, 2003; Kajikawa et al., 2007; Mauriello et al., 2004; Tacket et al., 1997;
Wu and Chung, 2007; Yang et al., 1990; Zhang et al., 2006). These vaccines have an advantage
over other types of vaccines in that they are able to be delivered directly to a mucosal surface via
nasal, ocular, or oral administration, which may enhance mucosal immune response, the primary
surface through which most pathogens invade.
Presently, multiple Salmonella subunit vaccines were developed to test possibility of
providing cross-serogroup protection, plus protection against Campylobacter in order to improve
vaccination strategies and effectiveness in the poultry industry, by providing an orally effective
vaccine. These vaccines were modified to insert highly conserved antigenic epitopes of
peptidoglycan associated lipoprotein (PAL) of Salmonella and Campylobacter Omp18 protein
Cj0113 (CJ0113; Layton et al., 2011). Additionally, a portion of chicken high mobility group box
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1 protein (HMGB1) was included as an immune enhancing molecule to promote uptake by antigen
presenting cells. A challenge with Salmonella Heidelberg provided for testing of cross-serogroup
protection with S. Enteritidis vectored vaccine candidates.
2.3 Materials and Methods
2.3.1 Vaccine Construction
Overview of mutational strategy. The strategy used for construction of the vaccine strains in both
S. Enteritidis and S. Typhimurium backgrounds was previously described (Cox et al., 2007).
Briefly, in this two-step mutagenesis process, the I-SceI site/kanamycin resistance (Kmr) cassette
was first inserted into the lamB gene by Red recombinase-mediated homologous recombination
via selection with kanamycin. Then, this mutation was replaced by the linear fragment carrying
desired insertion sequence encoding combinations of PAL, CJ0113 and HMGB1 sequences in
three different orders (Fig. 1). For the selection of the desired mutant, the linear PCR product
carrying the desired insertion sequence was transformed simultaneously with the plasmid, pBC-ISceI, expressing I-SceI homing endonuclease enzyme used for counter-selection against the strains
carrying the I-SceI site (Cox et al. 2007).
Bacterial Strains and Culture Conditions. SE164 strain, which carries I-SceI/Kmr cassette in the
loop 9 region in lamB gene and also contains plasmid pKD46, was used for construction of the
three SE vaccine strains in this study (Cox et al. 2007). For vaccines based on S. Typhimurium
background, the wild type S. Typhimurium 110 (ST) was used first for construction of the
attenuated strain with deletion in aroA gene, and the I-SceI/Kmr cassette was inserted into the loop
9 region of lamB gene via Red recombination in this study as previously described (Cox et al.
2007). Luria-Bertani (LB) media was used for routine growth of Salmonella cells, and 2×YT broth
(Thermo Fisher Scientific, Cat. #22712-020) for the preparation of electro-competent cells. SOC
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media (Invitrogen, Carlsbad, CA, USA) was used for phenotypic expression after electroporation.
The following antibiotics were added to the media when appropriate: ampicillin (Amp) at 100
μg/ml, kanamycin (Km) at 50 μg/ml, and chloramphenicol (Cm) at 25 μg/ml.
Plasmids. Plasmids pKD46 used in the present study was described previously (Cox et al., 2007;
Datsenko and Wanner, 2000). Plasmid pKD46 encodes Red recombinase enzymes that mediate
homologous recombination of incoming linear DNA with chromosomal DNA. This plasmid also
contains the ampicillin resistance gene (Ampr) and has a temperature-sensitive replicon, requiring
30°C for maintenance of the cell. Plasmid pBC-I-SceI expresses the I-SceI enzyme, which cleaves
the rare SceI sites of 18 bp long (Cox et al., 2007; Kang et al., 2004). Also, plasmid pBC-I-SceI
carries the chloramphenicol resistance (Cmr). Plasmids pCJ0113, pPAL and pHMGB1, which
carry individual epitope sequences CJ0113, PAL, and HMGB1, respectively, were synthesized by
GeneScript®. These plasmids were used as templates for PCR amplification of respective DNA
fragments.
PCR. All primers used for PCR are listed in Table 1. Typical PCR conditions consisted of
approximately 0.1 μg of purified genomic, plasmid or PCR-generated DNA, 10× cloned Pfu
polymerase buffer, 5 U Pfu polymerase (Stratagene La Jolla, CA, USA), 1 mM dNTPs (GE
Healthcare Bio-Sciences Corp., Piscataway, NJ), 1.2 μM each primer in a total volume of 50 μL.
The DNA engine thermal cycler (Bio-Rad, Hercules, CA, USA) was used with the following
amplification conditions: 94°C for 2 minutes; 30 cycles of 94°C sec for 30 sec, 58°C for 60 sec,
72°C for 90 sec per 1 kb; and 72°C for 10 minutes for final extension. Each PCR product was gelpurified (Qiagen, Valencia, CA, USA) and eluted in 20 μL EB buffer for preparation of templates
used in overlapping extension PCR. For the linear overlapping PCR product, the product was gel-
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purified and eluted in 50 μL EB buffer, ethanol precipitated, and resuspended in 5 μL of ddH 2O
for concentration, which then was used for electroporation.
Transformation. Transformation of pKD46 into S. Typhimurium was the first step carried out so
that Red recombinase enzymes could be used for mediating recombination between a linear PCR
product and chromosomal DNA. Plasmid pKD46 was used for transformation into S.
Typhimurium 110 by electroporation. Briefly, cells were inoculated into 10 mL of 2X YT broth
and grown at 37°C overnight. Then 100 μL of overnight culture was re-inoculated into 10 ml fresh
2 × YT broth at 37 °C for 3–4 hours until OD600 reached 0.8-1.0. Then, the cells were heated at
50°C for 25 minutes to inactivate host restriction system temporarily. Cells were washed five times
in 10% glycerol and resuspended in 60 μl of 10% glycerol. Cells were then electrically pulsed at
2400–2450 kV for 1–6 ms, followed by shaking in SOC medium (500µl) for 2–3 hours at 30°C
and plated on LB agar media with ampicillin. S. Typhimurium transformants carrying pKD46 were
maintained at 30°C. When these transformants were prepared for Red recombination-based
homologous recombination through electroporation, all steps were the same except that 15%
arabinose was added to induce Red recombinase enzymes one hour prior to washing, and cells did
not undergo the 50°C heating step.
Construction of intermediate construct carrying I-SceI/Kmr. Construction of Salmonella
Enteritidis (SE) mutant strain carrying the I-SceI/Kmr fragment in the loop 9 region of the lamB
gene and plasmid pKD46 (SE164) was described previously (Cox et al. 2007). The equivalent
intermediate construct for S. Typhimurium 110 was constructed essentially by the same method.
However, prior to insertion of the I-SceI/kmr, the aroA gene in S. Typhimurium was deleted as
described previously (Cox et al. 2007) for virulence attenuation. Briefly, the deletion aroA gene
was performed by inserting the Kmr gene in place of and thereby deleting aroA. This was done by
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first by amplifying the aroA upstream (primers aroA-1F and aroA-1R), and downstream (aroA-2F
and aroA-2R) sequences, which was joined with the Kmr cassette amplified from plasmid pKD4
using primers Kan 3F and Kan 3R (Table 1). This deletion cassette constructed by joining the 3
fragments by overlapping PCR was transformed into S. Typhimurium 110 strain, followed by
selection with kanamycin. Additionally, the previously described pCP20 was introduced into
ΔaroA cells to remove the Kmr gene from the aroA gene locus (Cox et al. 2007).
Construction of the vaccine strains surface-displaying three epitopes. The first step was to
amplify the linear PCR fragments that carry the DNA sequences of the three epitopes PAL (P),
CJ0113 (C) and HMGB1 (H) in different orders along with four spacers of serine residues as shown
in Fig. 1. The DNA codons for encoding the amino acids for the epitopes as well as serine (TCC)
were optimized for the most frequently used codons in Salmonella proteins (Burns and Beacham,
1985). The designs and DNA sequence of the primers are shown in Fig. 1 and Table 1, respectively.
To simplify the construction steps, the same lamB up and lamB dn fragments were commonly used
for construction of all 3 epitope cassettes. The sequence of CJ0113 in the cassette CHP and CPH
or HMGB1 in the cassette HCP was amplified to include a region overlapping with the 3’ end of
the lamB up fragment. The sequence of PAL in the cassette CHP, and HCP or HMGB1 in the
cassette CPH was amplified to include a region overlapping with the 5’ end of the lamB down
fragment. For each cassette three individual fragments were separately amplified from relevant
plasmids (pCJ0113, pPAL and pHMGB1), and were joined together by overlapping PCR. Then,
each of the overlapping PCR products was joined to the common lamB up and lamB dn fragments
by overlapping PCR to obtain the epitope cassettes that consist of lamB up-3 epitopes-lamB dn as
shown in Fig. 1.
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Genomic replacement of I-SceI/Kmr with three epitope sequences. The resulting epitope cassettes
and the plasmid pBC-I-SceI (at a molar ratio of approximately 40:1) were simultaneously
electroporated into the competent cells of SE and ST background, which carried the I-SceI/Kmr
cassette in loop 9 of the lamB gene and plasmid pKD46. Colonies for each recombination mutation
were chosen according to the ability to grow on Cm plates, but not on Km plates, due to the
replacement of Sce-I-Kmr cassette with the incoming epitope cassette. Finally the vaccine
candidates were verified by DNA sequencing using primers lamb-3f and lamb-3r, which are
located outside of the loop 9 up and dn regions.

2.3.2 Experimental Design
In all in vivo challenge experiments, chickens were raised in floor pens with wood shavings
and were separated by solid panel walls to prevent cross-contamination with live vectored vaccines.
Broilers were provided feed and water ad libitum, and diet was formulated to meet or exceed
nutritional requirements. Ambient temperature in the rearing facility was maintained at ageappropriate levels. All experiments were conducted under University of Arkansas Institutional
Animal Care and Use Committee approved protocols.
Bacterial cultures. Challenge strain of Salmonella Heidelberg (SH) was a field isolate confirmed
to serogroup level by agglutination with O factor antiserum (Becton, Dickinson and Co., Sparks,
MD) and typed by the National Veterinary Services Laboratories (Ames, IA, USA). Cultures were
prepared by growth in tryptic soy broth (TSB, Becton, Dickinson and Co., Sparks, MD) for
approximately 8 h each for three passages by transferring 1% of culture to fresh TSB. The cells
were washed three times in sterile saline by centrifugation (1,864 × g), and the approximate
concentration of the stock solution was determined spectrophotometrically. The stock solution was
serially diluted and confirmed by colony counts of three replicate samples plated on XLT4 agar
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(Becton, Dickinson and Co., Sparks, MD) plates. For cecal recovery of SH after challenge, birds
were killed by CO2 inhalation and entire ceca aseptically removed. Samples were diluted 1:4 w:v
in sterile saline, 100 µL removed for CFU determination by serial plating on XLT4 agar, while the
remaining portion was enriched in tetrathionate broth (Becton, Dickinson and Co., Sparks, MD)
by overnight incubation at 37 °C, followed by plating on XLT4 agar.
The challenge strain of Campylobacter jejuni was a field isolate confirmed by culture
techniques and microscopic observations of typical Campylobacter morphology. For recovery,
approximately 6 cm of the lower ileum was aseptically collected into sterile sample bags, diluted
1:4 w:v in sterile saline, then stomached for 10s, plus a portion of diluted ceca supernatant (above)
was serially diluted.

Intestinal samples were directly plated onto selective Campylobacter

chromogenic agar (R-F Labs, Downers Grove, IL). After incubation for 48 h at 42 °C under
microaerophilic conditions, colonies consistent with Campylobacter were enumerated.
Experiment 1. All six vaccine candidates were tested by oral gavage of approximately 1x107
CFU/chick, 20 chicks per each vaccine, on day of hatch and d14. Three days after boost
vaccination (d17 of age), 6x106 CFU/chicken of SH were administered by oral gavage as a
challenge dose, and negative control received sterile saline carrier. Recovery of SH was tested 5d
(d23 of age) and 10d (d28 of age) post-challenge.
Experiment 2. In this experiment, only the three SE-vectored vaccine candidates, SE-CPH, SEHCP, and SE-CHP, were tested for protection against SH challenge after a single vaccination. On
day of hatch, approximately 1x108 CFU/chick was administered to 20 chicks per vaccine, and the
negative control received a sterile saline carrier. On d7 all chicks were challenged with 7x106
CFU/chick of SH by oral gavage, and cecal samples were collected 21d (d28 of age) and 28d (d35
of age) post-challenge. Campylobacter recovery was performed at 28d post-challenge only.
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Experiment 3. In the final experiment, only SE-CPH vaccine was tested against SH challenge with
a spray vaccination instead of oral gavage to simulate conditions likely to be applied in a hatchery
setting. On day of hatch 50 chicks, per group, were placed in a cardboard hatchery transport box,
blocked off to provide chicks with typical spacing, which was then placed into a commercial
vaccine spray chamber that was loosely covered with plastic on each end to prevent escape of
sprayed vaccine. Control chicks were sprayed with saline carrier, and an estimated dose of 1.6x107
CFU/chick was sprayed into the cabinet for treated chicks. Particle size of the spray was confirmed
by collection of spray onto a microscope slide, and measured at ~6 µm droplets. Birds were
challenged with SH on d14 with 3x107 CFU/chick, followed by collection of ceca at 4d (d18 of
age), 7d (d21 of age), and 12d (d25 of age) post-challenge.

2.3.3 Statistical Analysis
Numerical data from all experiments were subjected to ANOVA (SAS Institute, 2002). Log10
CFU values per sample are expressed as mean ±standard error of mean and deemed significant at
P ≤0.05. The data were also subjected to mean separation using Duncan's multiple range test of
significance.
2.4 Results
2.4.1 Construction and confirmation of the vaccine strains
After electroporation colonies were chosen as the candidates according to the ability to grow
on Cm plates, but not on Km plates. Colony PCR was conducted using candidate colonies with
lamb-3f and lamb-3r primers that anneal outside of the lamB up and lamB dn regions. When the
expected size of the PCR products of approximately 726bp was confirmed by gel electrophoresis,
the PCR product was gel-purified for DNA sequencing. The colonies for which DNA sequencing
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data confirmed the insertion of the correct sequence for each epitope cassette in the correct location
in the lamB loop 9 region were stored at -80ºC with 30% glycerol.

2.4.2 Experiment 1
Five days post SH challenge (DPC), negative control birds tested positive at a mean level
of 1.19±0.26 log10 CFU/g of ceca, whereas SE-CPH vaccinated chickens had a recovery level of
only 0.34±0.23 log10 CFU/g of ceca which was significantly lower when the groups were directly
compared by t-test (Table 2). Levels of SH recovered from ceca of other challenged groups at 5
DPC were 0.69±0.53 log10 CFU/g (SE-HCP), 0.64±0.48 log10 CFU/g (SE-CHP), 3.02±0.57 log10
CFU/g (ST-CPH), 0.94±0.63 log10 CFU/g (ST-HCP), and 0.68±0.28 log10 CFU/g (ST-CHP). Ten
DPC, ST-HCP vaccinated group dropped SH level to 0.51±0.26 log10 CFU/g, which was
significantly lower than the control group, by direct comparison, at 1.36±0.23 log10 CFU/g. Levels
of SH recovery from the SE-CPH rose to 0.40±0.40 log10 CFU/g, which was different from control
group (p=0.0514) by direct comparison.

2.4.3 Experiment 2
After day of hatch vaccination, chickens were challenged with SH on day, followed by
detection of the challenge strain 21 and 28 DPC. At 21 DPC (or Twenty one DPC?), vaccine
candidate SE-CPH was the only vaccination group to have significantly lower recovery of SH from
the ceca than negative control at 4.71±0.55 vs. 6.16±0.13 log10 cfu/g (Table 3). Though the
difference between 21 and 28 DPC was less than 0.1 log10 change for SE-CPH vaccine group,
negative control recovery dropped to 5.11±0.59 log10 cfu/g, and the significant difference did not
persist. Camylobacter recovery was highest in the ceca (Figure 2), with levels ranging from
7.14±0.29 log10 cfu/g after SE-CPH vaccination to 7.70±0.29 log10 cfu/g in the non-vaccinated
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control group. Levels of Campylobacter recovered in the ileum were much lower with a range of
0.17±0.17 log10 cfu/g recovered from SE-CHP vaccinated birds to 1.05±0.57 log10 cfu/g in SEHCP vaccinated birds. There were no statistical differences among any of the groups for
Campylobacter levels.

2.4.4 Experiment 3
Only SE-CPH vaccine candidate was tested in Experiment 3, with a time course study to
evaluate persistence of protection. Four and seven DPC, recovery of SH in vaccinated chickens
was 2.7±0.0 log10 cfu/g and 1.89±0.41 log10 cfu/g, respectively. Compared to recovery in negative
control group, at 5.61±0.36 log10 cfu/g (4 DPC) and 3.98±0.47 log10 cfu/g (7 DPC), a significant
reduction was observed (Figure 3). However, by 12 DPC, the difference in cecal SH recovery was
reduced to 3.93±0.66 log10 cfu/g in negative control and 3.01±0.92 log10 cfu/g in vaccinated
treatment, which was not significantly different.
2.5 Discussion
Construction of all 6 vaccine strains described in study was constructed essentially by the
method previously established in our lab (Cox et al. 2007). Once the epitope cassettes of different
designs were prepared by overlapping PCR, the construction of the vaccine strains carrying the
epitope cassettes was a straightforward process. In the final constructs, the antibiotic resistance
cassette (Kmr cassette) was removed and replaced by the desired epitope cassette, making them
free of antibiotic markers. Once the final constructs were confirmed at DNA sequence level, the
functional expression of each of the epitopes was also confirmed by standard antibody
agglutination assays with hyper-immune sera against each of the antigens.
The first vaccine experiment evaluated six different SE and ST vectored vaccines, each
containing CJ0113, PAL, and HMGB1 genetic inserts in different patterns, against SH challenge.
22

Five days after challenge SE-CPH vaccinated chickens had reduced recovery of SH from ceca,
with a trend in reduction ten DPC (P=0.0514) and 0.96 Log10 CFU/g reduction in cecal recovery
(Table 2). Vaccination with ST-HCP also resulted in reduced recovery of SH from cecal tonsils,
when compared directly to the negative control group, but only at ten DPC. Given the overall lack
of reduction in SH recovery 5 DPC with ST-vectored vaccine candidates, they were not carried
forward in subsequent experiments. Though, not all the SE-vectored strains were effective at a
significant reduction in SH detected, there was some numerical differences, and all three vaccines
were re-evaluated. As suggested previously, this lack of effectiveness could be related to natural
folding and expression of the antigen epitopes on the cell surface in a manner that inhibited
antigenicity or immunogenicity. Experiment 2 tested only SE vectored vaccine candidates against
SH challenge and recovery at 21 and 28 days post challenge. Only SE-CPH resulted in decreased
cecal recovery of SH with a 1.45 Log10 CFU/g reduction, and no vaccine group had lower recovery
by 28 days post infection (Table 3). These results at least partially confirmed results of Experiment
1, in that only SE-CPH was able to provide protection, evidenced by the >96% decrease in SH at
21 days post challenge, and that SE-HCP and CHP were not as robust as providing protection
against colonization. This study also evaluated effect of vaccination against Campylobacter jejuni
challenge, with samples collected from ileum and ceca 28 days post challenge. Contrary to
previous studies utilizing CJ0113 antigen (Layton et al., 2011), no statistically significant
reduction of Campylobacter was observed (Figure 2). However, these results are not entirely
inconsistent with Layton et al. (2011) which reported efficacy of an SE vectored CJ0113 vaccine
against C. jejuni recovery in ileum of chickens. In that report, C. jejuni was detected by
quantitative PCR techniques with a limit of detection at 1.0 Log10 CFU. Thus, had the present
study followed the detection techniques, it is unlikely that C. jejuni would have been detected in
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chickens vaccinated with SE-CHP, but it should be noted that ileum levels of C. jejuni in the
Negative Control group also would have been low, and were much lower than those reported by
Layton and co-workers (2011).

Recent changes in culture detection techniques and better

understanding of Campylobacter infection in poultry, such as ceca as the primary site of infection
versus ileum (Bahrndorff et al., 2015; Chaloner et al., 2014; Chintoan-Uta, 2016) likely account
for differences between this and the previous report. It should also be noted that the previous
research report inserted a CD154 immune-enhancing molecule instead of the HGMB1 molecule
used in these studies, which may have accounted for differences.
The final experiment investigated the ability of a single day of hatch vaccination by SECPH to reduce levels of SH in ceca at four, seven, and twelve days post-challenge. Early recovery
time points, four and seven DPC, had significantly lower levels of SH in vaccinated groups.
However, a decline in levels in Negative Control combined with an increase in SE-CPH vaccinated
group, negated this difference by 12 DPC (Figure 3. Re-infection of GIT is possible through
coprophagic activity in poultry and these data suggest that a single vaccination likely does not
provide long term immune protection against re-infection from exposure later in life.
The purpose of testing protection of SE-vectored vaccination against SH was to determine
the ability of the vaccine to provide cross-serogroup protection in broilers because 92% of
Salmonella positive samples from broilers analyzed under the Food Safety and Inspection Service
HACCP program in 2014 were represented across three different serogroups, suggesting that a
vaccine capable of providing protection across these serogroups would have great impact on
reduction of Salmonella on poultry products (United Stated Department of Agriculture, 2016).
Though S. Kentucky was the highest isolated serotype, it is not among serotypes commonly
associated with human illness. Thus, SH was selected due to the ability to prove both cross
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serotype and serogroup protection among ST or SE vaccinated chickens. These studies showed
that vaccination with SE vectored subunit vaccine containing the highly conserved antigen PAL
was able to confer protection against SH challenge for up to 21 days post-infection. Salmonella
Typhimurium vector was able to reduce SH recovery up to 10 days post-infection in the single
experiment tested.
Subunit vaccines expressing cross-protective antigens may be useful for the poultry
industry due to ability to reduce levels of Salmonella across multiple serotypes and serogroups,
thus effectively reducing levels of Salmonella on animals as they enter processing facilities. The
studies presented here were primarily aimed at the ability of a highly conserved antigen, PAL,
expressed in a double-attenuated SE (serogroup D) strain to provide protection against a SH
(serogroup B) strain, as well as an attenuated ST strain to provide protection against SH. Results
indicate that live attenuated vaccination with a serogroup D Salmonella Enteritidis subunit
vaccines containing antigen PAL and the immune enhancing molecule HMGB1 can reduce cecal
levels of serogroup B Salmonella Heidelberg, suggesting that cross-serogroup protection against
Salmonella infection in poultry is achievable.
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2.8 Figures and tables
Figure 1. Construction of the 3 epitope cassettes using overlapping PCR. A. CPH, B. HCP,
and C. CHP.

29

Table 1. Oligonucleotides used in this study
Homology sequence
lam-up-f
lam-up-r
lam-dn-f
lam-dn-r
lamb-3f
lamb-3r

lamB up
lamB dn
Checking epitope insertion

TGTACAAGTGGACGCCAATC
GTTATCGCCGTCTTTGATAT
ATTTCCCGTTATGCCGCAGC
GTTAAACAGAGGGCGACGAG
ATGATGATTACTCTGCGCAA
CGCTGGTATTTTGCGGTACA

CJ113 ＋ PAL + HMGB1
LC-F

LamB up + (Ser)3 + CJ0113

CP-R

CJ0113 + (Ser)3 + PAL

CP-F

(Ser)3 + PAL

PH-R

PAL + (Ser)3 + HMGB1

PH-F

(Ser)3+ HMGB1

HL-R

HMGB1 + (Ser)3 + LamB

AAATGGGGCTATATCAAAGACGGCGATAACTCCTCCTCCG
GTGTTTCTATCACCGTTGAA
ACGTTCGTCCGCGTGACCTTCGGAGGAGGACGCCTGGTTG
TATTCGTCGG
TCCTCCTCC GAAGGTCACGCGGACGAACGT
ACGCGGTTTTTTCGGGTCGCCTTTACCCAT GGAGGAGGAA
CGTTCACCCAGAGAGATGTTGTATT
Same as CP-F
GGAGTTAGTCGCTGCGGCATAACGGGAAATGGAGGAGGA
GTCTTCTTCTTCTTCTTTTT

HMGB1 + CJ0113 + PAL
LH-F

LamB + (Ser)3 + HMGB1

HC-R

HMGB1 + (Ser)3 + CJ0113

HC-F

(Ser)3 + CJ0113

CP-R

CJ0113 + (Ser)3 + PAL

CP-F

(Ser)3 + PAL

PL-R

PAL + (Ser)3 + LamB

AAATGGGGCTATATCAAAGACGGCGATAACTCCTCCTCCA
TGGGTAAAGGCGACCCGAAA
TTCAACGGTGATAGAAACACCGGAGGAGGAGTCTTCTTCT
TCTTCTTTTT
TCCTCCTCC GGTGTTTCTATCACCGTTGAA
ACGTTCGTCCGCGTGACCTTCGGAGGAGGACGCCTGGTTG
T ATTCGTCGG
Same as CP-F
GGAGTTAGTCGCTGCGGCATAACGGGAAATGGAGGAGGA
ACGTTCACCCAGAGAGATGTTGTATT

CJ113 ＋ HMGB1 ＋ PAL
LC-F

LamB up + (Ser)3 + CJ0113

CH-R

CJ0113 + (Ser)3 + HMGB1

CH-F

(Ser)3 + HMGB1

HP-R

HMGB1 + (Ser)3 + PAL

HP-F

(Ser)3 + PAL

PL-R

PAL + (Ser)3 + LamB

AAATGGGGCTATATCAAAGACGGCGATAACTCCTCCTCCG
GTGTTTCTATCACCGTTGAA
TTTCGGGTCGCCTTTACCCAT GGAGGAGGACGCCTGGTTG
TATTCGTCGG
TCCTCCTCC ATGGGTAAAGGCGACCCGAAA
ACGTTCGTCCGCGTGACCTTC GGAGGAGGAGTCTTCTTCT
TCTTCTTTTTTTTTTTTAGA
Same as CP-F
GGAGTTAGTCGCTGCGGCATAACGGGAAATGGAGGAGGA
ACGTTCACCCAGAGAGATGTTGTATT

Deletion of aroA gene
aroA-1F

aroA up

CTGGACGTCTCTCGCTATGG
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aroA-1R
aroA-2F

aroA dn

aroA-2R
Kan 3F
Kan 3R

Kmr gene in pKD4

TAGGAACTTCGAAGCAGCTCCAGCCTACACATAAAAACCC
CACAGACTGG
GGAATAGGAACTAAGGAGGATATTCATATGGTCTTCTGT
TGCGCCAGT
CTTGCGAGAGTGCCCTAAAG
GTGTAGGCTGGAGCTGCTTC
CATATGAATATCCTCCTTAG

Underline indicates the nucleotides corresponding to overlapping regions.
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Table 2. Recovery of Salmonella Heidelberg from ceca after vaccination by oral gavage on
day of hatch and 14 days of age, Experiment 1. On day of hatch and day 14, chickens were
vaccinated with respective antigen-vectored vaccines, challenged with 6x106 cfu/chick of S.
Heidelberg on d17, and ceca were collected for recovery 5 and 10 days post challenge (DPC).
Log10 S. Heidelberg
(CFU/gram)
5 DPC
10 DPC
Negative Control
SE-CPH
SE-HCP

1.19±0.26ab
0.34±0.23b*
0.69±0.53b

1.36±0.23a
0.40±0.40a**
1.08±0.49a

SE-CHP
0.64±0.48b
1.10±0.39a
ST-CPH
3.02±0.57a
1.45±0.48a
ST-HCP
0.94±0.63b
0.51±0.26a*
ST-CHP
0.68±0.28b
1.16±0.45a
ab
Values with different superscripts are
significantly different P<0.05
*Different from Negative Control P<0.05 by
direct comparison
** P=0.0514 (SE-CPH vs. Negative Control)
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Table 3. Recovery of Salmonella Heidelberg from ceca after vaccination by oral gavage on
day of hatch, Experiment 2. On day of hatch, chickens were vaccinated with respective
antigen-vectored vaccines, challenged with 6x106 cfu/chick of S. Heidelberg on d7, and ceca
were collected for recovery 21 and 28 days post challenge (DPC).

Negative Control
SE-CPH
SE-HCP
SE-CHP

Log10 S. Heidelberg
21 DPC
28 DPC
a
6.16±0.13 5.11±0.59a
4.71±0.55b 4.80±0.57a
6.32±0.15a 5.16±0.18a
5.94±0.18a 5.31±0.19a
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Figure 2. Recovery of Campylobacter from ceca after vaccination by oral gavage on day of
hatch, Experiment 2. On day of hatch, chickens were vaccinated with respective antigenvectored vaccines, challenged with Campylobacter jejuni, and ceca and ileum were collected for
recovery 28 days post challenge (DPC).
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Figure 3. Recovery of Salmonella Heidelberg from ceca after vaccination by spray
administration on day of hatch, Experiment 3. On day of hatch, chickens were vaccinated
with SE-CPH vaccine, challenged with 3x107 cfu/chick of S. Heidelberg on d14, and ceca were
collected for recovery 4, 7 and 12 days post challenge (DPC).
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3.1 Abstract
Salmonella is an important foodborne bacterial pathogen, however, a fundamental
understanding on Salmonella transmission routes within a poultry flock remains unclear. In this
study, a series of barcode-tagged strains were constructed by inserting six random nucleotides into
a functionally neutral region on the chromosome of S. Enteritidis (SE) as a tool for quantitative
tracking of Salmonella transmission in chickens. Six distinct barcode-tagged strains were used for
infection or contamination at either low dose (103 CFUs; 3 strains) or high dose (105 CFUs; 3
strains) in three independent experiments (Exp 1 oral gavage; Exp 2 contaminated feed; Exp 3
contaminated water). For all chick experiments, cecal and foot-wash samples were collected from
a subset of the chickens at Days 7 or/and 14, from which genomic DNA were extracted and used
to amplify the barcode regions. After the resulting PCR amplicons were pooled and analyzed by
MiSeq sequencing, a total of approximately 1.5 million reads containing the barcode sequences
were analyzed to determine the relative frequency of every barcode-tagged strain in each sample.
In Exp 1, the high dose of oral infection was correlated with greater dominance of the strains in
the ceca of the respective seeder chickens, and also in the contact chickens yet at lesser degrees.
When chicks were exposed to contaminated feed (Exp 2) or water (Exp 3), there was no clear
patterns of the barcode-tagged strains in relation to the dosage, except that the strains introduced
at low dose required a longer time to colonize the ceca with contaminated feed. Most foot-wash
samples contained only 1 to 3 strains for the majority of the samples, suggesting potential existence
of a unknown mechanism(s) for strain exclusion. These results demonstrated the proof of concept
of using barcode-tagged to investigate transmission dynamics of Salmonella in chickens in a
quantitative manner.
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3.2 Introduction
Salmonella species induce bacterial illness and are also one of the leading causes of
hospitalization among all the foodborne bacterial pathogens (1, 2). According to the Centers for
Disease Control and Prevention (CDC), there is approximately 1.2 to 4 million human Salmonella
infections in the United States each year (3, 4, 36). There are multiple sources of Salmonella
infection in humans such as consumption of contaminated food and water, or contact with infected
animals (5). Among others, poultry products are a prominent source of human salmonellosis, and
the contamination can originate from a multitude of sources during poultry production (6-8). S.
Enteritidis is considered as one of the most commonly identified serovars in association with
human infection in the United States (9). The number of human infections by S. Enteritidis
continued to increase from the 1980s, and had reached the point where S. Enteritidis became the
predominant serovar in the 1990’s and currently still remains a prominent foodborne diseasecausing serovar (10, 34). Therefore, it is critical to not only understand the transmission modes of
S. Enteritidis in chicken flocks, but to also be able to quantitate their relative contribution of each
route to contamination during poultry production. Knowing the quantitative contribution of
various transmission routes would be very helpful in designing optimal strategies to minimize the
spread of Salmonella within a chicken flock via interventions such as vaccines and antimicrobials
administered in the feed or drinking water (37, 38).
The transmission of Salmonella in a chicken flock involves an initial infection with single or
multiple Salmonella strains from different sources through oral or tracheal routes (11-15). While
the oral route is believed to be the primary infection route of Salmonella based on experimental
evidence (1, 2), there are indications that airborne transmission is also a possible route (16-19).
Once infection occurs the Salmonella population disseminates in the host from the entry site and
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may colonize the intestinal tract or systemically invade the host tissues (20). Once a host becomes
infected locally in the intestinal tract or systemically, Salmonella can, in turn, be disseminated to
other susceptible hosts (21).
Salmonella, as an enteric pathogen, can be disseminated to poultry flocks through several
sources. Drinking water, feed, wildlife or pets, transportation mode, manure or litter can be
vehicles contributing to dissemination of Salmonella into poultry (41). Water is an important
vehicle and can serve as a reservoir for Salmonella dissemination. Salmonella possesses the
capacity to not only survive in the water for a long period of time but the expression of key
virulence factors can also be increased when Salmonella is exposed to stressors in a water
environment (40). Salmonella appear to possess the mechanisms to retain viability and
successfully survive in the river environments as well. The relationship between the contaminated
feed and the occurrence of Salmonella in poultry has been substantiated by several studies (44, 45).
For the reason of labor and technical simplification, most chicken feed is produced in the farm as
milled and blended mash, most of which are not heat-treated or pelleted. The vertical integration
nature of the commercial poultry production cycle could impact the risk of introducing pathogens
such as Salmonella to poultry production as a result of contaminated feed (42, 43).
Quantitative resolution of critical routes for Salmonella establishment in chickens requires the
ability to track the strains introduced to the flock distinctively using some sort of a recoverable
signature. Traditionally, Salmonella monitoring has been based on techniques such as introducing
foreign elements into the candidate strain to construct marker strains that are antibiotic resistant or
express genes for fluorescence proteins (22-24). However, these methods risk introducing
phenotypic features into the resulting marker strains that could alter the pathogenicity and
physiological status such that the resulting strains no longer behave in exactly same fashion as the
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corresponding wild type. For example, green fluorescence proteins have been shown to alter
growth physiology, while exposure to nalidixic acid can influence gene expression (25, 26). It is
well established that acquisition of antibiotic resistance often entails fitness cost or enhanced
fitness of the pathogenic strains in the absence of selection pressure (39).
The objective of the present study was to evaluate the proof of concept of barcode-tagged
isogenic strains of Salmonella Enteritidis in broiler chickens using different routes of infection. A
series of isogenic S. Enteritidis strains in which distinct DNA barcodes were inserted in a
functionally neutral locus in the genome were constructed and the resulting strains employed to
quantitatively track the transmission routes of the respective strains by profiling the barcoderegions using high-throughput sequencing. The advantages of these barcode-tagged strains over
previously used marker strains are that each strain can be tracked quantitatively as a distinguishable
part of the entire population at high accuracy, allowing for differentiation among multiple barcodetagged strains as well as discrimination from the environmental Salmonella without altering
phenotypes or behaviors during infection, colonization and dissemination.
3.3 Materials and Methods
3.3.1 Bacterial Strains and Culture Condition
Salmonella enterica serovar Enteritidis phage type 13A strain, which is a primary poultry
isolate, was originally obtained from the USDA National Veterinary Services Laboratory (Ames,
IA). The plasmid pKD4 was used as a template to amplify the kanamycin-resistance gene for
construction of the barcode-tagged strains. The Escherichia coli strain BW25141 carrying pKD4
was inoculated in Luria-Bertani (LB) broth overnight and plasmid pKD4 was extracted with the
illustra plasmidPrep Mini Spin Kit (GE Healthcare Life Sciences). The Salmonella Enteritidis
strain (SE) containing pKD46 that encodes Red recombinase system was used for construction of
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barcode-tagged strains via electroporation (46, 47). The plasmid pKD46 contains an ampicillinresistance gene and is also a temperature-sensitive replicon requiring 30°C for replication of the
plasmid in the cell. LB broth was used for cultivation of barcode-tagged strains. Super optimal
broth with catabolite repression (SOC) media (Invitrogen, Carlsbad, CA, USA) was used for
phenotypic expression of the transformed cells immediately after the electroporation. Appropriate
antibiotics were used at the following concentrations when necessary: kanamycin (Km) at 50
μg/ml and ampicillin (Amp) at 100 μg/ml.

3.3.2 Rationale for the Genomic Location Selection
Ideally, the barcode along with the kanamycin resistance gene should be inserted into a
functionally neutral genomic locus. Based on Chaudhuri et al. (27) we first searched for two
adjacent genes that are not required for intestinal colonization in chickens and are also transcribed
toward each other. We determined that SEN1521 and SEN1522 met these conditions, and therefore
the intergenic region (141 bp) between these two genes was selected for insertion of a barcode plus
the kanamycin resistance gene (Figure 1). When foreign sequences are inserted in the middle of
this intergenic region without removing any original genomic sequences, it can be ensured that the
insertion would not cause any polar effect on the downstream genes which would minimize, if any,
phenotypic change due to the barcode insertion.

3.3.3 Construction of Barcode-tagged strains
All PCR primers are listed in Table 1. The 3’ end and downstream regions of the coding genes
SEN1521 (232 bp) and SE1522 (267 bp) were amplified from the genomic DNA of S. Enteritidis
13A with the primer pairs of T1-F and T1-BC-P1-R, and T3-P2-F and T3-R, respectively (termed,
upstream and downstream fragments, respectively) (Figure 1). The T1-BC-P1-R primer contained

41

a barcode of 6 random nucleotides and the sequence overlapping with 5’ end of the Km resistance
gene (P1). The T3-P2-F primer contained the sequence overlapping with 3’ end of the Km gene
(P2). The Km resistance gene (1,496 bp) was amplified from the plasmid pKD4 with the primer
pair of P1 and P2. The PCR assays were conducted by combining approximately 0.1 μg of purified
genomic DNA or plasmid along with 1 µl of 2.5 U/µl Pfu polymerase (Agilent Technologies), 5µl
of 10× cloned Pfu polymerase buffer, 4 µl of 2.5 mM dNTPs (TaKaRa) and 1 µl of 1.2 μM of each
primer resulting in a total volume of 50 μL. The DNA Engine

®

Thermal Cycler (Bio-Rad,

Hercules, CA, USA) was used with the following amplification cycles: 94°C for 2 minutes; 30
cycles of 94°C sec for 30 sec, 58°C for 60 sec, 72°C for 60 sec per 1 kb; and 72°C for 10 minutes
for the final extension. Each PCR product was gel-purified and eluted in 25 μl EB buffer for
preparation of templates to be used for overlapping extension PCR. Overlapping extension PCR
was employed to join the three fragments (upstream fragment plus a barcode + Km resistance gene
+ downstream fragment) together with the primers T1-F and T3-R (Figure 1). After running the
agarose gel for confirmation of the correct size, electroporation was used to introduce the
overlapping PCR fragments into S. Enteritidis carrying pKD46 plasmid. A number of
transformants selected on LB agar plates supplemented with Km were first analyzed by PCR for
the presence of the barcode plus kanamycin resistance gene in the correct genomic locus with the
primers BC-F and BC-R, and, if positive, analyzed for barcode sequences by Sanger sequencing
of the PCR products. Finally, we isolated and confirmed 10 barcode-tagged strains carrying unique
barcodes. Six of them were used in this study, and the barcodes in the respective strains were: BC1
(CTCCAA), BC2 (TGTCAT), BC3 (ACGGGC), BC4 (CACCCG), BC5 (CTCATC), and BC6
(GCCGAC).
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3.3.4 Chicken Infection Experiments
All animal procedures in this study were conducted in accordance with the protocol approved
by the University of Arkansas Institutional Animal Care and Use Committee. In all experiments,
day-of-hatch broiler chicks were obtained from Cobb-Vantress (Siloam Springs, AR). To test the
utility of the barcode-tagged strains for quantitative tracking of Salmonella transmission, we set
up three independent experiments as describe below.

3.3.5 Oral Infection into Seeder Chickens Experiment 1.
Six chickens were randomly selected for oral infection with Salmonella barcode-tagged strains
(referred to as seeder chickens hereafter) on day 1. Three of the chickens (seeder chickens #1
through 3) were orally infected at low dose (103 CFUs) with BC1, BC2 and BC3 strains,
respectively. The other three chickens (seeder chickens #4 through 6) were orally infected at high
dose (105 CFUs) with BC4, BC5 and BC6 strains, respectively. The other 10 chickens were not
infected with any barcode-tagged strains, and were referred to as contact chickens (# 7 through
16). Seeder and contact chickens were housed together for the 14 days. On the day 7 post-infection
three contact chickens (# 7 through 9) were euthanized and cecal contents were removed and stored
at -20°C for genomic DNA isolation. Each bird foot was washed thoroughly in 5 ml of PBS buffer
in a sterile Ziploc bag, and bacterial cells from the rinse were subsequently harvested via
centrifugation at 5, 000 rpm for 10 mins. The bacterial pellets were stored at -20°C and used for
genomic DNA isolation. On the day 14 post-hatch, four seeder chickens (chick 1, 4, 5, 6; chick #2
and 3 were not sampled) and four contact chicks (chick 10 through 13) were also euthanized and
cecal contents as well as foot wash were collected for DNA isolation as describe previously.
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3.3.6 Consumption of Contaminated Feed Experiment 2.
The same six barcode-tagged strains were used to inoculate a balanced antibiotic-free
corn/soybean based diet at 2 different levels: at low dose (103CFUs) with BC1, BC2, and BC3
strains, respectively, and at high dose (105 CFUs) with BC4, BC5, and BC6 strains, respectively.
To minimize the volume of the liquid inoculum, the cell suspension of each barcode-tagged strain
was concentrated to contain the target cell number in 1 l inoculum. Feed (1.36 kg) on the feeder
was inoculated with 1 l of the inoculum for each of the six barcode-tagged strains. Sixteen
chickens were allowed to consume this contaminated feed for 48 hours. After two days, the
contaminated feed was replaced by Salmonella-free feed and water ad libitum. On day 7 and 14,
two and four chickens were euthanized, respectively. For each euthanized bird, both ceca and footwash samples were collected and processed by the same procedures described previously.

3.3.7 Drinking Water Administration Experiment 3.
This experiment was set up essentially in the same way as Experiment 2, except that the six
barcode-tagged strains were added to and mixed in 11.36 liters of drinking water. Chickens (n=
16) were allowed to drink ad libitum this contaminated water for 48 hours. After two days the
contaminated water was replaced with Salmonella-free fresh water. On the day 7 and 14 four
chicks were euthanized respectively. Cecal and foot-wash samples were collected and processed
by the same procedure described previously.

3.3.8 Illumina Sequence Sample Preparation
Genomic DNA was isolated from each sample using QIAamp DNA MiniKit (Qiagen). The
concentration of purified DNA was measured by a Qubit3.0 Fluorometer (ThermoFisher
Scientific). Subsequently, the barcode regions in the extracted genomic DNA of each sample were
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amplified using the primers BC-F and BC-R (Table 1), and G2 PCR mixture (Promega) with an
initial incubation of 2 min at 95°C followed by 35 cycles of 30 s at 94°C, 1 min at 55°C, and 1
min at 72°C followed by a 10 min extension at 72°C. The PCR products of 191 bp were purified
by using a QIAquick PCR purification kit (Qiagen) for use as a template in the next round of PCR.
The second step PCR was conducted to attach Illumina-specific sequences along with the
combinatorial sample index sequences (6 nt) on both ends using the Illumina Index forward and
reverse primers shown in Table 1. A total of 9 Illumina Index forward and 6 Illumina Index reverse
primers were used, allowing up to 54 (9 x 6) samples to be sequenced simultaneously. The resulting
amplicons of 167 bp were purified by ethanol purification method and were pooled together to
generate an amplicon library for MiSeq sequencing with single-end read option via 150 cycles.

3.3.9 Analysis of DNA sequencing results
Custom Perl script was used to perform the following data analysis: First, the barcode regions
of 57 bp in the sequence reads from Illumina MiSeq data were extracted. The 12 bp-index
sequences were obtained by extracting and combining forward Index sequence (6 bp) and reverse
index sequence (6 bp), and used to sort the barcode reads to different samples. The 6 different
barcodes were subsequently extracted and used to determine the relative abundance of different
barcode-tagged strains in each sample.
3.4 Results and Discussion
3.4.1 Quantitative Profiling of Barcode-tagged Strains
A total of 1,461,014 sequence reads of 150 bp was obtained from the MiSeq sequencing run.
The sequence reads were binned into different files according to the combinatorial index sequences
corresponding the samples from the three experiments. If any reads did not match perfectly to one
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of the original six barcode sequences they were subsequently deleted. Since the read numbers
reflect only relative frequency of each barcode-tagged strain in a given sample, the original read
numbers were converted to calculate the percentage of each barcode-tagged strain in each sample.

3.4.2 Experiment 1: Salmonella Transmission after Oral Infection
The results of the transmission of the SE barcode-tagged strains the cecal content and foot
wash of seeder chickens on Day 14 from Experiment 1 are summarized in Table 2. For cecal
samples of the seeder bird #1, which was infected with BC1 strain at low dose (103 CFUs), the
BC1 strain was the predominant colonizer (46.37 %), however, the other strains challenged at a
higher dose (105 CFUs) were also recovered from cecal content of chicken 1: BC3 (20.40 %), BC4
(29.63 %), and BC5 (3.59 %). These results suggest that a significant mixed infection by different
S. Enteritidis BC strains could occur when the chick was infected by barcode-tagged strains at low
dose and subsequently comingled with other infected chickens. The barcode-tagged strains used
in this study are isogenic strains with the identical genome sequence except for the barcode region.
Therefore, it is possible that the multiple barcode-tagged strains may be recognized as the same
strains from each other and/or by the host, leading to avoidance of the exclusion mechanism(s)
observed among different strains as has been described previously in chickens and mammals (29
- 31). In the seeder chickens #4, #5 and #6 infected by respective barcode-tagged strains at high
dose, the barcode-tagged strains used for infection were the dominant strains (93.21%, 98.56%,
and 99.94%, respectively) in the ceca (Table 2). It appears that barcode-tagged strains introduced
at high dose saturated all potential colonization niches, thus impeding colonization by other strains.
This phenomenon observed in the chicks infected by a high dose of Salmonella is consistent with
the colonization-inhibition theory (29, 30). In conclusion, these results suggest that the outcome
of cecal colonization in terms of the number of the barcode-tagged strains colonizing the ceca is
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dose-dependent, and a high dose beyond a certain threshold level results in dominant colonization
by a single strain.
Contamination of feet by dominant barcode-tagged strains occurred for the seeder chickens
#1, #4 and #6 (93.57 % of BC6, 99.55 % of BC5, and 78.86 % of BC6, respectively), but they
were not necessarily the same strains used for infection of the same chickens (Table 2). For the
case of the seeder #5, the foot was contaminated by three strains, BC4, BC5, and BC6 strains
(36.77 %, 52.97 %, and 21.10 %, respectively) among which BC5 was the one used for oral
infection of the bird. The vast majority of the strains contaminating feet were those used for
infection at high dose (BC4, BC5, and BC6), which indicated that high dose of Salmonella BCs is
widely disseminated in the environment and thus may frequently be isolated from the feet.
However, there is no correlation between the orally infected strain and dominant strain occurring
on the feet. It is possible that the major strain isolated from the feet is from the environment instead
of coming from chick itself.
Figure 2 shows the results of the transmission of the S. Enteritidis barcode-tagged strains in
the oral infection model in contact chickens. For the contact chickens, almost all (99%) of the
barcode-tagged strains colonizing ceca on day 7 were strains administered at high dose, namely
BC4-6. However, on day 14, a more diverse set of barcode-tagged strains were detected from the
ceca of contact chickens, including a greater proportion of the barcode-tagged strains that were
used to infect seeder chickens at low dose (BC1-3). It seems that the contact chickens are more
likely to be colonized by the strains initially used for infection at high dose, but they eventually
become colonized in the ceca also by the strains originating from the low dose as time progresses
(Figure 2). In contrast, foot-wash samples from all contact chickens did not reveal any obvious
trends as compared to those observed in cecal samples. On day 7, BC3 strain, which was
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administered at low dose, was the only strain (100%) contaminating the foot of the contact bird
#7. Conversely the feet of the contact chickens #8 and 9 were colonized mainly by the two strains,
BC4 and BC6, which were used for infection at high dose. After the passage of time the barcodetagged strain populations on the feet of the contact chickens became more diverse on day 14.
Comparing the relative abundance between day 7 and 14 indicated that the barcode-tagged strains
that were used for infection at low dose increased the chances to contaminate the feet with the
exception of BC3, which was not detected on the feet of any bird on day 14.

3.4.3 Experiment 2: Salmonella Transmission after Infection through Contaminated Feed
The results of the transmission of the SE barcode-tagged strains in a feed contamination model
(Experiment 2) are shown in Figure 3. On day 7 the ceca from the two chickens were colonized
mainly by the barcode-tagged strains that were introduced at the higher dose. On day 14 the ceca
from the bird #4 and 6 were predominantly colonized by BC3 (91%) and BC2 (94%) (both were
introduced at a low dose), respectively, while the bird #5 was exclusively colonized by BC5. On
day 14, only bird #3 showed colonization by multiple strains, mostly BC1 (44%) and BC6 (51%)
strains. By comparing the combined percentages of the low versus high dose strains in the ceca at
the day 7 (0 versus 100%) and day 14 (60% versus 40%), it is apparent that the strains introduced
to feed at a low dose eventually colonized the ceca, but it required a much longer period of time
when compared to the strains introduced at high dose. Greater diversity of the strains was also
detected at the day 14 as compared to the day 7 for the feet samples with the exception of the bird
#3 (Figure 3).
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3.4.4 Experiment 3: Salmonella Transmission after Infection through Contaminated Drinking
Water
Figure 4 summarizes the results of the transmission of the SE barcode-tagged strains in water
contamination model (Experiment 3). When the chicks were infected through contaminated
drinking water, only three barcode-tagged strains (BC2, BC3, and BC6), representing both the
strains that had been introduced at low and high dose, were recovered from the ceca on day 7 and
14. Strain BC6 (high dose), which was the predominant cecal colonizer, was also detected as the
predominant strain contaminating the feet. Interestingly, BC1 (a low dose challenge strain), even
though not detected in the ceca of any chicken at any time, was recovered as the predominant strain
in the feet of the chickens (Figure 4). Since only 8 chickens were analyzed out of the total of 16
chickens, BC1 is probably the predominant colonizer in at least one of the remaining chickens that
was not used for sample collection.
3.5 Conclusions
Salmonella transmission in chicken flocks have already been the subject of several studies in
which the Salmonella strains introduced to the flock were identified and quantified by culturing
on selective agar plates and confirmed by biochemical and serological methods (48-53). In the
studies conducted by De Vylder et al. (50) and Thomas et al. (51, 52) single Salmonella Enteritidis
strains were used to analyze different aspects of Salmonella transmission within the laying hen
flocks. These approaches have been useful in understanding the impact of different phage type
strains or housing system on the frequency of horizontal transmission (50, 53, 54) or measuring
different parameters of Salmonella transmission (51). However, detailed picture of the
transmission involving interactions among multiple strains or serotypes cannot be investigated
using the culture methods, due to the inability to differentiate multiple strains based on the culture
methods.
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Several investigators have study the persistence of horizontal fecal shedding of Salmonella
Enteritidis in experimentally infected laying hens housed on different commercial conditions (53,
54). However, these studies are still limited to reflect the complexity of the environmental
conditions that Salmonella is exposed to during transmission in a poultry farm. The other weakness
of culture method approaches is that the isolated strains may be from environment rather than the
strain externally introduced as a part of an experimental infection, thus handicapping the ability to
differentiate the corresponding strain. Even though the strain might be confirmed as an
experimental strain by further characterization, the result can only indicate the presence of the
strain and reliable quantification is not possible
In order to quantitatively track the Salmonella transmission routes from environment to flock,
we constructed a series of barcode-tagged strains, which carry distinct barcode tags that would
allow them to be identified and quantified accurately by high-throughput sequencing of the
barcode regions. The similar methods of barcode-tagging have been applied to understand the
transmission dynamics within the infected hosts for Salmonella (32, 33), other pathogenic bacteria
(28) and viruses (35). However, to our knowledge this is the first report on the application of the
barcode-tagged strains to study transmission dynamics within a population of the host animals. In
this study, we used the barcode-tagged strains of S. Enteritidis to understand the transmission
dynamics of Salmonella in a quantitative manner after initial introduction through oral infection,
or consumption of contaminated feed or drinking water.
In the current study six barcode-tagged S. Enteritidis strains were employed to infect six
chickens (seeder chickens) orally in oral infection experiment. In contaminated feed and water
study the same six barcode-tagged strains were introduced into feed or water in each isolator.
Following the exposure via different routes, the corresponding distributions of the six different
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barcode-tagged strains at different colonization sites (ceca and feet) were analyzed at different
time points post-infection.
Utilizing PCR and Illumina MiSeq analysis the population structure could be assessed and
representative transmission figures could be constructed. The results are important for
understanding the patterns of S. Enteritidis dissemination in poultry and are revealing by
demonstrating that a higher dose of S. Enteritidis has a greater opportunity to infect flocks. In
addition, the data from this study suggests that colonization-inhibition by competing Salmonella
is somewhat dosage dependent. Based on qPCR result for quantification of the combined load of
all barcode-tagged strains (not shown) it appears that recovery of S. Enteritidis barcode-tagged
strains introduced orally were not different among the seeder chickens and contact chicks in both
cecal and foot-wash samples on day 14. All barcode strains combined in the cecal samples
remained stable on days 7 and 14 in Experiment 1, while those from foot-wash samples increased
10 fold in the three experiments after time had elapsed.
To better establish the implications for commercial poultry production settings, larger scale
experiments are needed to assess additional environmental and host factors. However, the current
experiment demonstrated the proof of concept that the use of barcode-tagged strains is a novel and
an effective approach to understand the dynamics of Salmonella transmission within a chicken
flock and can provide valuable insights for the potential to develop and optimize measures that
protect host animals from infection with Salmonella. Studies to evaluate and confirm previous
work published by our laboratory (14-16, 20) that demonstrate the importance of airborne
transmission of Salmonella versus oral infection as well as the competitive exclusion concept of
Salmonella versus Salmonella (55, 56) or cross protection (57-59) using these SE barcode-tagged
strains are currently being evaluated.
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3.8 Figures and Tables
Table 1. Oligonucleotides used in this study
Primers for construction of barcode-tagged strains (5’3’)
T1-F

GCAAGGTTGGTGTCTGTCCT

T1-BC-P1-R

GAAGCAGCTCCAGCCTACACNNNNNNATTATTGTTAATTTATTCTT

P1

GTGTAGGCTGGAGCTGCTTC

P2

ATGGGAATTAGCCATGGTCC

T3-P2-F

GGACCATGGCTAATTCCCATAAAGGTTAAGCAGTGACCCA

T3-R

GTTGATGGACTGGGTTCGTT

BC-F

AGCGTCCTGAAATAATAAAAGAA

BC-R

CGGACTGGCTTTCTACGTGT

Illumina Index Forward Primers (5’3’) *6nt-index sequences are underlined.
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTATCACGGCGTCCTGAAATAATAAAA
GAATAAA
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTCGATGTGCGTCCTGAAATAATAAAAG
AATAAA
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTTAGGCGCGTCCTGAAATAATAAAAG
AATAAA
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTGACCAGCGTCCTGAAATAATAAAA
GAATAAA
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTACATGTGCGTCCTGAAATAATAAAAG
AATAAA
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTGCCAATGCGTCCTGAAATAATAAAA
GAATAAA

Illumina Index Reverse Primers (5’3’) *6nt-index sequences are underlined.
CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTATCACGGAAGCAGCTCCAGCCTACAC
CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTCGATGTGAAGCAGCTCCAGCCTACAC
CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTTTAGGCGAAGCAGCTCCAGCCTACAC
CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTTGACCAGAAGCAGCTCCAGCCTACAC
CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTACATGTGAAGCAGCTCCAGCCTACAC
CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTGCCAATGAAGCAGCTCCAGCCTACAC
CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTCAGATCGAAGCAGCTCCAGCCTACAC
CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTACTTGAGAAGCAGCTCCAGCCTACAC
CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTGATCAGGAAGCAGCTCCAGCCTACAC
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Table 2. Relative abundance of the Salmonella Enteritidis (SE) barcode-tagged strains in seeder
chickens on Day 14 in the cecal content and foot wash from Experiment 1.

Ceca Content
BC1

BC2

BC3

BC4

BC5

BC6

Chicken 1
BC1/ 103

46.37 %

0.00 %

20.40%

29.63 %

3.59 %

0.01 %

Chicken 4
BC4/ 105

0.04 %

0.004%

0.00%

93.21 %

6.74 %

0.01 %

Chicken 5
BC5/ 105

0.04 %

0.01%

0.27%

0.00 %

98.56 %

1.12 %

Chicken 6
BC6/ 105

0.03 %

0.00%

0.004%

0.00 %

0.03 %

99.94 %

Foot Wash
BC1

BC2

BC3

BC4

BC5

BC6

Chicken 1
BC1/ 103

0.03 %

6.37 %

0.00 %

0.00 %

0.02 %

93.57 %

Chicken 4
BC4/ 105

0.42 %

0.01 %

0.00 %

0.01 %

99.55 %

0.00 %

Chicken 5
BC5/ 105

0.04 %

0.003 %

0.00 %

36.77 %

52.97 %

10.21 %

Chicken 6
BC6/ 105

0.03 %

0.005 %

0.00 %

0.002 %

21.10 %

78.86 %

Six chickens were randomly selected for oral infection with Salmonella barcode-tagged strains on
day 1. Chickens 1 through 3 were orally infected with 103 CFUs with BC1, BC2 and BC3 strains,
respectively. Chickens 4 through 6 were orally infected with 105 CFUs with BC4, BC5 and BC6
strains, respectively. At 14 days post challenge, cecal content or foot wash sample were collected
from each chicken and used for isolation of genomic DNA. Following PCR and MiSeq analysis
of barcode regions, to the number of the sequence reads corresponding to different barcodes were
used to determine the relative abundance (%) of each SE barcode strain from each chick. Chickens
2 and 3, orally gavaged with BC 2 and BC 3 were not sampled in this experiment.
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Figure 1: Schematics of the construction of barcode-tagged Salmonella Enteritidis 13A strains
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Figure 2. Transmission of the Salmonella barcode-tagged strains in contact chickens in oral
infection model. In Experiment 1 six seeder chickens were infected by different dose of SE
barcode strains (BC1 and BC2 and BC3 are used for infection of three chickens at 103 CFUs; BC4
and BC5 and BC6 are used for infection of other three chickens at 105 CFUs). Other 10 chickens
were roomed together with these six seeder chickens and named as contact chickens. Three contact
chickens were euthanized on day 7 and four contact chickens were euthanized on day 14. The cecal
tonsil and foot wash samples were collected from each chicken by aseptic technique. X-aixs
represents different contact chickens from Experiment 1 and y-axis represents different SE barcode
strains. The number in bubble presents the relative abundance of each barcode strain in each
chicken. Bigger size and red color means the higher relative abundance, and smaller size and blue
color means lower relative abundance.
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Figure 3. Transmission of the Salmonella barcode-tagged strains in feed contamination
model. In Experiment 2 the feed was contaminated by 6 SE barcode strains at two doses (BC1 and
BC2 and BC3 were introduced into the feed at 103 CFUs, BC4 and BC5 and BC6 were at 105
CFUs on day 1). Two chickens were euthanized on day 7 and the other four chickens were
euthanized on day 14. The cecal and foot wash samples were collected from each chicken by
aseptic technique and used for isolation of genomic DNA. Following PCR and MiSeq analysis of
barcode regions, to the number of the sequence reads corresponding to different barcodes were
used to determine the relative abundance (%) of each SE barcode strain from each sample.X-axis
represents different chickens from Experiment 2 and y-axis represents different SE barcode strains.
Bigger size and red color means the higher relative abundance, and smaller size and blue color
means lower relative abundance.
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Figure 4. Transmission of the Salmonella barcode-tagged strains in water contamination
model. In Experiment 3 the water was contaminated by 6 SE barcode strains at two doses (BC1
and BC2 and BC3 were introduced into the water at 103 CFUs, BC4 and BC5 and BC6 were at
105 CFUs on day 1). Four chickens were euthanized on day 7 and the other four chickens were
euthanized on day 14. The cecal and foot wash samples were collected from each chicken by
aseptic technique and used for isolation of genomic DNA. Following PCR and MiSeq analysis of
barcode regions, to the number of the sequence reads corresponding to different barcodes were
used to determine the relative abundance (%) of each SE barcode strain from each sample. X-axis
represents different chickens from Experiment 2 and y-axis represents different SE barcode strains.
Bigger size and red color means the higher relative abundance, and smaller size and blue color
means lower relative abundance.
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CHAPTER FOUR
Salmonella excludes Salmonella in poultry: Confirming an old paradigm
using conventional and barcode-tagged isogenic strains
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4.1 Abstract
Salmonella is one of the major foodborne pathogens and chickens play an important role
as a reservoir for introducing Salmonella from the environment into becoming a public health
concern. However, the mechanism of Salmonella transmission within the chicken flock is not fully
understood, including the competitiveness among Salmonella strains when infecting and
colonizing chickens. The purpose of the present study was to evaluate the competitive exclusion
between Salmonella spp. consecutively challenged through the oral route. Different approaches
were used to evaluate the competitive exclusion effect including tracking Salmonella transmission
by wild-type strains or DNA barcode-tagged isogenic strains. Using wild-type strains, chicks were
predominantly colonized by the first serovar administered at day one, ranging from 82.5 to 86.7%
of recovery. A similar trend was also found by using barcode-tagged strains ranging from 91.3 to
97.8% of recovery of the first barcoded strain administered. However, mixed colonization by two
barcoded strains existed when these strains were given on the second day. These results provide
quantitative evidence for the competitive exclusion theory that oral administration of Salmonella
will produce predominant inhibition over the subsequent colonization of ceca by the following
Salmonella strain administered one day later. Therefore, utilizing barcode-tagged isogenic strains
and sequencing by Illumina sequencing can serve as a quantitative method for studying Salmonella
infection, transmission and colonization in poultry.
4.2 Introduction
As the highest foodborne illness cases caused by Salmonella, prevention of Salmonella
colonization in the gastrointestinal tract (GIT) of chickens is necessary, especially for newly
hatched chickens. The reason is that the normal microbiota cannot be fully developed until 6 weeks
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of age, which caused chickens to be vulnerable and susceptible of infection by Salmonella (Barnes
et al., 1972).
The live attenuated Salmonella vaccine strain has been identified as an effective approach
for controlling the colonization of pathogenic Salmonella in the GIT by potentially acting as
competitive exclusion (CE) and triggering the immune system (Methner et al 2011). The
characteristic of these vaccines should be nonpathogenic, be able to colonize in the GIT, therefore
exclude other Salmonella pathogenic strains. Dueger et al. (2002) constructed the Salmonella
Typhimurium vaccine strain by deleting the DNA adenine methylase genes and the vaccine strain
are demonstrated to provide cross-serotype protection against oral challenge with homologous and
heterologous Salmonella serovars in mice and chickens.
These vaccine strains reduce the ability of Salmonella colonization in the chickens may be
via stimulating cell-mediated immunity (Babu et al., 2004; Lillehoj et al., 2000). Another
possibility is that vaccination may alter the microbial composition and diversity in the chicken GIT
(Park et al., 2017). Crhanova et al. (2011) also suggested that attenuated Salmonella vaccines are
able to modify the chicken gut microbiota, enhance the gut immune system maturity, and then
increase resistance to infection by pathogenic strains. However, these mechanisms may not be the
only reason that a decrease Salmonella colonization occurs in the chickens, because the immunity
stimulation and microbiota change take a longer time than competitive exclusion mechanism.
Methner et al. (1999) proposed that vaccination of chicks at day one age ensures the colonization
by the vaccine strain, which produces an inhibitory effect and stimulates the development of an
immunological response to the following infection.
Barrow et al. (1987) also demonstrated that oral administration of live strains of foodborne
pathogenic Salmonella to day-old chickens produced inhibition in the subsequent colonization of
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the ceca by a strain of Salmonella Typhimurium (ST) given one day later. Remarkably, closely
related enterobacteria were unable to induce the same effect (Barrow et al., 1987). More recently,
Rabsch et al. (2000), with mathematical models that combined epidemiology and population
biology, demonstrated that Salmonella Enteritidis (SE) filled the ecological niche vacated by
eradication of Salmonella Gallinarum (SG) and Salmonella Pullorum (SP) from poultry. The
theory suggests that SG was able to competitively exclude SE from poultry flocks in the early 20th
century, and the elimination of SG and SP in poultry led to an epidemic increase of SE in poultry
and human infections in the 80’s. The cross-immunity between two serovars is probable.
Immunization of chickens with SG protects against colonization by SE, instead of ST, is possible
because SG and SE have the same immunodominant O-antigen on their cell surface (17-23 from
Rabsch 2000). Holt and Gast 2004 estimated that prior infection of hens with ST or Salmonella
Muenchen (SM) can reduce the infection by SE, which indicated that cross-serovar protection
existed among ST, SM and SE. In vitro experiment conducted by Calo et al. (2014) exhibited a
decrease growth of ST when Salmonella Heidelberg is present in the spent media.
Based on the CE phenomenon that may exist between the same or different serovars, it is
important to employ an accurate approach and quantitatively measure CE. For analyzing the CE
theory, antibiotic marker strains are widely used as an approach, however, these marker strains do
not always behave in exactly same fashion as the corresponding wild type strains (Nutt et al. 2003).
Hence, it is critical to use the isogenic strains for studying CE to decrease the bias from different
infection strains. We have constructed a series of isogenic SE barcode-tagged strains in which
distinct DNA barcodes were inserted in a functionally neutral locus in the genome of SE and the
resulting strains can be used to quantitatively track the colonization of the respective strains by
profiling the barcode-regions using a high-throughput sequencing method (Yang et al., 2017). The
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advantages of these barcode-tagged strains over previously used marker strains are that each strain
can be tracked quantitatively as a distinguishable part of the entire population at high accuracy,
allowing for differentiation among multiple barcode-tagged strains as well as discrimination from
the environmental bacteria or viruses without altering phenotypes or behaviors during infection,
colonization and dissemination (Yang et al., 2017)(Varble et al., 2014)(Troy et al., 2013). The
purpose of the present study was to evaluate the competitive exclusion of Salmonella consecutively
or simultaneously challenged with SE or ST in poultry using conventional and barcode-tagged
isogenic strains.
4.3 Materials and Methods

4.3.1 Project 1: Recovery of Salmonella from Leghorn Chicks Consecutively or Simultaneously
Challenged with SE or ST

4.3.1.1 Salmonella Cultures
A highly invasive poultry isolate of SE was obtained from the USDA National Veterinary
Services Laboratory (Ames, IA 50011). The isolate was selected for resistance to 25 µg/mL
novobiocin (Sigma, St. Louis, MO) and 20 µg/mL nalidixic acid (NA, catalog no. N-4382, Sigma).
This strain of SE was also found to be naturally sensitive to 10 µg gentamicin (GM10) on antibiotic
sensitivity discs. An invasive isolate of ST (ATCC13311) was also selected for resistance to NO
and NA for use in these experiments. This ST was resistant to GM10. For the present studies, 100
µL of SE or ST (depending on the trial) from a frozen aliquot was added to 10 mL of tryptic soy
broth (TSB, catalog no. 211822, Becton Dickinson, Sparks, MD) and incubated at 37°C for 8 h.
This was followed by 3 passages every 8 h into fresh TSB, for a total of 24 h, to ensure log phase
growth. Post incubation, bacterial cells were washed 3 times in sterile 0.9% saline by
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centrifugation (1,864 × g, 4°C, 15 min), quantified with a spectrophotometer (Spectronic 20D+,
Spectronic Instruments Thermo Scientific, Waltham, MA) at 625 nm using an established
concentration curve, and diluted in sterile 0.9% saline as per required concentrations (cfu/mL) for
the trials. Concentrations of SE or ST were also determined retrospectively by serial dilution and
further plating onto brilliant green agar (BGA, catalog no. 70134, Sigma) with NO and NA for
enumeration of actual cfu per milliliter used for challenge, as reported below.
4.3.1.2 Experimental Birds
Naïve, day-old single comb white Leghorn male chicks were obtained from a local
hatchery and randomly placed in cages (N=10 or 20 chicks/cage) within electrically heated starter
batteries located within a modern biological hazard isolation unit on the research farm of the
College of Veterinary Medicine, Texas A & M University. Chickens were provided ad libitum
access to water and a balanced unmedicated corn-soybean diet meeting the nutrition requirements
of poultry recommended by the NRC (1994). Adequate body temperature was maintained using
heat lamps within the isolators. All animal handling procedures were in compliance with
Institutional Animal Care and Use Committee at Texas A & M University. Twelve chickens for
each trial were humanely killed and sampled upon arrival at the laboratory. Whole ceca-cecal
tonsils (CCT), liver, spleen and yolk sac were aseptically removed from these neonatal chicks,
incised, and cultured in 10 mL of tetrathionate enrichment broth (TEB) (Tet, catalog no. 210420,
Becton Dickinson, Sparks, MD) and incubated overnight at 37°C. The samples were confirmed
negative for Salmonella by plating them on to selective BGA with NO and NA.
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4.3.1.3 Experimental design
Experiment 1 consisted of two independent trials. In trial 1, on day one, two groups were
orally gavaged with 104 cfu/mL ST. On day two, two groups were orally gavaged with 105 cfu/mL
SE. Twenty-four hours post challenge, chickens were euthanized and cultured for Salmonella
recovery in CCT. Briefly, whole CCT were enriched in tetrathionate enrichment broth (TET,
catalog no. 210420, Becton Dickinson, Sparks, MD) and incubated for 24 h at 37°C. Samples
were taken from the enriched broth and subcultured on BGA plates containing 20 µg/mL NA and
25 µg/mL NO for approximately 18 hours at 37 °C. Ten isolated colonies from the control groups
were taken from each BGA and lined onto Mueller-Hinton plates (Finegold and Baron, 1986).
Twenty isolated colonies from the treatment groups were lined onto Mueller-Hinton plates. An
antibiotic sensitivity disc of GM10 was placed on each line and the results tabulated 24 hours later
as either Resistant=ST or Sensitive=SE. Approximately 20 isolates were randomly selected during
these experiments and serogrouped using commercially available antisera to verify accuracy of
serovar separation. Trial 2 was performed in the same manner as trial 1 except that SE was used
for the first challenge (104 cfu/mL) on day one, which was followed by ST challenge (105 cfu/mL)
on day 2.
Experiment 2 includes independent trial 3 and 4. Trial 3 includes 3 groups. On day one,
group 1 (N=20) were orally gavaged with 2 × 104 cfu ST, group 2 (N=20) were orally gavaged
with 2 ×104 cfu SE, and group 3 (N=20) were orally gavaged with 2 ×104 cfu SE and 2 ×104 cfu
ST simultaneously. Twenty-four hours later, the chicks were euthanized and cultured for
Salmonella recovery from CCT. Trial 4 was performed in the same manner as trial 3 except that
SE and ST were administrated on day 2.
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4.3.2 Project 2: Recovery of Barcode-tagged Isogenic Strains with Illumina Sequence PCR in Dayold Broiler Chickens

4.3.2.1 Construction of Barcode-tagged Strains
The method for construction of barcode-tagged strains is described in a previous
publication (Yang et al., 2017). Briefly, SE containing pKD46 that encodes Red recombinase
system was used for construction of barcode-tagged strains via electroporation. Overlapping
extension PCR was employed to join the three fragments (upstream fragment plus a 6 nt random
barcode + Km resistance gene + downstream fragment) together. After electroporation, the
mutants carrying the barcode sequence along with the kanamycin resistance gene inserted into a
functionally neutral genomic locus, SEN1521 and SEN1522, were selected and used in this study
as previously described in detail (Yang et al. 2017).
4.3.2.2 Bacterial Strains and Culture Condition
SE barcode-tagged isogenic strains were incubated overnight at 37°C in Luria-Bertani (LB)
broth with kanamycin (50 µg/ml), and were harvested by centrifuge at 4°C. The cell pellet was
washed three times and resuspended in distilled 0.9% saline. A suspension of 108 colony forming
units (cfu)/ml was obtained by using a spectrophotometer to agjust OD625 =0.147. The suspension
inocula were subsequently diluted into 105 cfu/ml for infecting chicks.
4.3.2.3 Experimental Birds
Day-of-hatch, male broiler chickens were obtained from Cobb-Vantress (Siloam Springs,
AR) and placed in floor pens with a controlled age-appropriate environment. Chickens were
provided ad libitum access to water and a balanced unmedicated corn-soybean diet meeting the
nutrition requirements of poultry recommended by the NRC (1994). Adequate body temperature
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was maintained using heat lamps within the isolators. All animal handling procedures were in
compliance with Institutional Animal Care and Use Committee at the University of Arkansas.
Twelve chickens for each trial were euthanized and sampled upon arrival at the laboratory as
described in experiment 1.
4.3.2.4 Experimental Design
This experiment was set up to confirm if oral administration with one SE barcode-tagged
strain inhibits the colonization by the other SE barcode-tagged strain in the ceca of chickens. A
total of 90 day-of-hatch broiler chicks were randomly separated into six groups (N = 15
chicks/group). In Group 1, all chickens were orally gavaged with 105 cfu/mL of SE barcode-tagged
strain BC1 on day 1 and on day 2 they were gavaged with 0.9% sterile saline. In Group 2, all
chickens were orally gavaged with 105 cfu/mL of SE barcode-tagged strain BC2 on day 1 and on
day 2 they were gavaged with sterile saline. In Group 3, all chickens were orally gavaged with
0.9% sterile saline on day 1 and on day 2 they were gavaged with 105 cfu/mL of SE barcodetagged strain BC1. In Group 4, all chickens were orally gavaged with 0.9% sterile saline on day 1
and on day 2 they were gavaged with 105 cfu/mL of SE barcode-tagged strain BC2. In Group 5,
all chickens were orally gavaged with 105 cfu/mL of SE barcode-tagged strain BC1 on day 1 and
on day 2 they were gavaged with 105 cfu/mL of SE barcode-tagged strain BC2. In Group 6, all
chickens were orally gavaged with 105 cfu/mL of SE barcode-tagged strain BC2 on day 1 and on
day 2 they were gavaged with 105 cfu/mL of SE barcode-tagged strain BC1. On day three, 12
chickens from each group were euthanized. Cecal contents and liver/spleen were collected,
smashed, and suspended in 0.9% saline in 1:4 ratio in sterile bags. One mL of suspension from
each bag was collected for genomic DNA isolation.
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4.3.2.5 Illumina Sequence Sample Preparation and Analysis of DNA Sequencing results
These procedures are the same as Yang et al. (2017). Briefly, genomic DNA were isolated
from each sample, from which the barcode regions were amplified first by PCR. The PCR products
were purified and used as the template in the next round PCR. The second step PCR was conducted
to attach Illumina-specific sequences along with the combinatorial sample index sequences (6 nt)
on both ends using the Illumina index forward and reverse primers. The resulting amplicons were
isolated by the ethanol purification method and were pooled together to generate an amplicon
library for MiSeq sequencing. Custom Perl script was used to perform the Illumina Miseq data
analysis.
4.3.2.6 Statistical Analysis
The enrichment data were expressed as positive/total chickens (%) and the percent
recovery of Salmonella was compared using the chi-squared test of independence, testing all
possible combinations to determine the significance (P ≤ 0.001) for these studies (Zar, 1984).
Barcode % recovery data within experimental groups were subjected to one way ANOVA (SAS
Institute, 2002). Barcode % recoveries were expressed as means ±SEM and deemed significant if
P ≤ 0.001. The data were also subjected to mean separation using Tukey’s multiple range test
significance.
4.4 Results
4.4.1 Recovery of Salmonella from Leghorn Chicks Consecutively or Simultaneously Challenged
with SE or ST
The recovery of Salmonella in CCT from consecutive different Salmonella serovar
challenges in day-old Leghorn chicks in trial 1 and trial 2 of Experiment 1 are shown in Table 1.
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In both trials, each serovar was recovered from CCT following single administration respectively.
However, when ST was administered on day one at 104 cfu, followed by the consecutive challenge
of SE twenty-four hours later at 105 cfu, the birds were predominantly colonized by ST (81.6 %),
the first serovar administered (P < 0.001). In no case was SE alone, the second serovar
administered, isolated from any bird. Those colony isolates, which were serotyped as SE, came
only from birds with mixed infections. In addition, these colony isolates were significantly lower
for SE recovery (2.91 %) as compared to 100 % in the SE controls chickens. Similar effects were
observed in trial 2, when chickens were challenged with SE on day one at 104 cfu followed by the
consecutive oral challenge of ST on day two at 105 cfu. In this trial, SE, the first serovar
administered, dominated (82.5 %) in those birds cultured. Colonies isolated as ST from CCT were
significantly lower at 3% respectively as compared to serotyped ST controls at 100%.
Two simultaneous Salmonella serovar challenges were performed in experiment 2. On trial
3, chicks were challenged with 104 cfu of ST and 104 cfu of SE on day one. Ninety percent of the
Salmonella-culture positive chicks exhibited mixed infections in CCT. Colony isolated from those
chicks that received both serovars simultaneously exhibited a mixed isolate profile in the CCT. In
trial 4, simultaneous Salmonella serovar challenges were performed on day 2 at 104 cfu. Overall
results in CCT were similar as seen in trial 3, with mixed Salmonella serovars recovered.
4.4.2 Recovery of Barcode-tagged Isogenic Strains with Illumina Sequence PCR in Day-old
Broiler Chickens
The results of the percentage Salmonella barcode strains recovered from cecal samples
enumerated from Illumina sequence data in day-old broiler chickens in Experiment 2 are
summarized in Table 3. A total of 3,138,578 sequence reads of 167 bp was obtained from the
MiSeq sequencing run. The sequence reads were binned into different files according to the
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combinatorial index sequences corresponding the samples from the four experiments. If any reads
did not match perfectly to one of the original six barcode sequences they were subsequently deleted.
Since the read numbers reflect only relative frequency of each barcode-tagged strain in a given
sample, the original read numbers were converted to calculate the percentage of each barcodetagged strain in each sample. Oral gavage of SE barcode-tagged strain BC1 on day one followed
by saline on day two in group 1 resulted in 97.77 % BC1 recovery. Similarly, in group 2,
administration of SE barcode-tagged strain BC2 on day one followed by saline on day two in group
2 resulted in 97.77 % BC2 recovery. However, oral gavage of barcode 1 on day one and barcode
2 on day two in group 5 resulted in 91.25 % barcode 1 recovery while only 0.5 % of barcode 2
was recovered. The opposite effect was observed when barcode 2 was administered first with
84.25 % recovery of barcode 2 and only 6 % of barcode 1 recovered from CCT. However, both
SE barcode-tagged strains could be isolated from ceca in the chicks from group 3 and 4, even
though only one single SE barcode-tagged strain was introduced on day two (Table 3). Figure 1
shows the percentage of each barcode-tagged strain in each cecal sample and figure 2 shows the
percentage of each barcode-tagged strain in each liver/spleen sample.
4.5 Discussion
It has been estimated that foodborne infections in the US cause over seventy six million
illnesses and are responsible for five thousand fatalities each year (Allos et al., 2004). In addition,
the annual economic losses attributed to the four most common enteropathogens (Salmonella spp.,
Campylobacter spp., E. coli and Shigella) have been estimated to reach $ 7 billion dollars (Archer
and Kvenberg, 1985). Hence, understanding the mechanisms of pathogenesis of enteropathogens
such as Salmonella, is still critical in order to find alternative methods to antibiotics that can
eliminate or reduce these pathogens from poultry products (Mead et al., 1999).
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Several investigators have also shown a significant protection from the second Salmonella
challenge with sequential administration of Salmonella serovars in mice (Collins, 1968) or chicks
(Barrow et al., 1990)(Barrow and Page, 2000)(Berchieri and Barrow, 1990). Early studies by
(Howard, 1961; Collins, 1968a) indicated that prior infection with ST could protect mice from the
intravenous challenge of another Salmonella serovar. Similar investigations have demonstrated
that intravenous challenge of SG caused protection against subsequent intravenous challenge with
SE (Collins et al., 1966). In their study, Collins et al. (1966) demonstrated that SG was able to
persist in the tissues therefore protecting against SE challenge. However, SP, an antigenically
similar organism, was unable to establish within the tissues which apparently allowed SE to
colonize. In addition, live attenuated Salmonella vaccines provide protection from subsequent
Salmonella challenges, without the virulence factor, within 4 weeks of vaccination (Copper et al.,
1992) (Dougan et al., 2011)(Berchieri and Barrow, 1990). Similarly, the results of the present
study confirm those by Barrow et al. (1987) in which day-old chicks which received sequential
Salmonella challenge resulted in an almost exclusive infection within 24 hours. Hence, regardless
of route of challenge, experimental animal or time between challenges, sequential Salmonella
challenges allow chickens to become refractory to the second Salmonella serovar administered.
The mechanism for resistance to sequential challenges has not been completely elucidated. Our
results suggest that Salmonella-infected chicks become refractory to a second challenge serovar
within 24 hours. These data confirm previous reports of rapid induction of resistance to
consecutive Salmonella challenge.
However, several investigators have evaluated Salmonella transmission in commercial
poultry flocks using conventional bacteriology and serological methods (Gast et al., 2014)(Grant
et al., 2008)(Thomas et al., 2011). Even though these studies have helped in understanding the
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impact of different phage type strains or housing system on the frequency of horizontal
transmission, comprehensive understanding of the transmission and pathogenesis involving
interactions among multiple serovar strains cannot be examined using the traditional culture
methods. In the present study, the use of two barcode-tagged SE were used to investigate
transmission dynamics of Salmonella in chickens in a quantitative manner. These strains have
served as an initial conceptional proof to quantitatively track the Salmonella transmission routes
from environment to flock, since they carry distinct barcode tags that would allow them to be
identified and quantified accurately by high-throughput sequencing of the barcode regions (Yang
et al., 2017). In summary, utilizing isogenic barcode-tagged strains, the population structure can
be quantified to evaluate the patterns of SE infection and dissemination in chickens, and determine
whether infection of neonatal chickens with one Salmonella strain, excludes the infection of a
second strain (cross protection). In order to better comprehend the implications of barcode-tagged
strains for commercial poultry, larger scale experiments are needed to assess additional
environmental and host factors. Nevertheless, the current experiment demonstrated that the use of
barcode-tagged strains is an original and an effective method to understand the dynamics of
Salmonella infection, which provides valuable opportunities to develop and improve measures that
protect poultry flocks from infection with Salmonella. Studies to evaluate and confirm previous
work published by our laboratory (Kallapura et al., 2014) that demonstrate the importance of
airborne transmission of Salmonella versus oral infection using these SE barcode-tagged strains
are currently being evaluated.
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4.7 Tables and Figures
Table 1. Consecutive Salmonella serovar challenges in day-old chicks following per os
administration of Salmonella Enteritidis or Salmonella Typhimurium in trial 1 and trial 2 of
Experiment 2.
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Table 2. Simultaneous Salmonella serovar challenges in day-old chicks following per os
administration of Salmonella Enteritidis or Salmonella Typhimurium in trial 3 and trial 4 of
Experiment 2.

*Asterisk within rows indicates significant difference at P < 0.001
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Table 3. Percentage Salmonella barcode strains recovered from cecal sample enumerated from
ilumina sequence data in day-old broiler chickens. Experiment 2.

Data expressed as Mean ±SE; n = 12 chickens
a,b

Values within treatment group (row) with different superscripts differ significantly (P < 0.001).

83

Figure 1: Percentage Salmonella Barcode-tagged Strains Recovered from Cecal Sample
Enumerated from Ilumina Sequence Data

Figure 2: Percentage Salmonella Barcode-tagged Strains Recovered from Liver/Spleen Sample
Enumerated from Ilumina Sequence Dat
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5.1 Abstract
The aim of the present study was to evaluate the microbiological properties of three
probiotic candidate strains of lactic acid bacteria (LAB) (128; 131; CE11_2), their effect on
intestinal epithelial permeability as well as their ability to reduce intestinal colonization of
Salmonella Typhimurium (ST) individually or as a batch culture in neonatal turkey poults. Isolates
were characterized morphologically, and identified by 16S rRNA sequence analyses. Additionally,
each of the isolates was evaluated for: Tolerance and resistance to acidic pH, high osmotic
concentration of NaCl, and bile salts resistance in broth medium. In vitro assessment of
antimicrobial activity against different enteropathogenic bacteria was determined with an overlay
technique. Moreover, in vitro intestinal permeability was evaluated using a stressed Caco-2 cell
culture assay treated with/without the probiotic candidates. However, the in vivo effect of the
selected LAB strains on ST cecal colonization was determined in two independent trials with
neonatal turkey poults. The results obtained in this study showed the tolerance of LAB candidates
to a pH of 3, NaCl concentration of 6.5 %, and high bile salts resistance (0.6 %). All strains
evaluated showed in vitro antibacterial activity against Salmonella Enteritidis, ST, and
Campylobacter jejuni. Candidates 128 and 131 showed coccus morphology and were identified as
Enterococcus faecium, whereas bacterial strain CE11_2 showed clusters of cocci-shaped
morphology and was identified as Pediococcus parvulus. All three candidate probiotics
significantly (P < 0.05) increased transepithelial electrical resistance (TEER) in Caco-2 cells
following a 3 h incubation period with hydrogen peroxide when compared with control and blank
groups. The combination of all three candidates as a batch culture showed significant efficacy in
controlling intestinal colonization of ST in neonatal turkey poults. Evaluation of the combination
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of these selected LAB candidate strains in performance and intestinal health parameters of
chickens and turkeys are currently in process.
5.2 Introduction
Prokaryotes are widespread in all environments, establishing diverse interactions with
many eukaryotic taxa (Bronstein et al., 2006; Gnad et al., 2010). The cooperative interactions
between species (mutualism) have a central role in the generation and maintenance of all forms of
life (Kikuchi et al., 2009; Jones et al., 2010). One example of a beneficial group of microorganisms
is the astonishing abundant ensemble of microbes that harbors in the gastrointestinal tract (GIT)
of metazoans (Neish, 2009). The GIT is more heavily populated with microorganisms than any
other organ and is an interface where the microbiota may have a pronounced impact on animal
biology (Yegani and Korver, 2008; Maslowski and Mackay, 2010; Musso et al., 2010). Clearly,
the association of gut microbiota is regulated by elaborate and combinatorial host–microbial and
microbial–microbial interactions developed over the course of evolution (Xu and Gordon, 2003);
(Xu et al., 2007; Fraune and Bosch, 2010). Comparison of gnotobiotic rodents with control rodents
colonized with a normal microbiota have revealed a wide range of host functions affected by
indigenous microbial communities such as assembly of the gut-associated lymphoid tissue;
integrity of the intestinal mucosal barrier; proliferation and differentiation of its epithelial lineages;
angiogenesis; and activation of the enteric nervous system (Bergman, 1990; Moran, 2007;
Duerkop et al., 2009; Martin et al., 2010; Sekirov et al., 2010; Tlaskalová-Hogenováet al., 2011;
Walter et al., 2011). The microbiota can metabolize a wide range of by product converting them
to end products including short chain fatty acids, a process which has direct benefits on digestive
physiology (Tellez et al., 2006; Dass et al., 2007; Tellez et al., 2012). As with most complex
ecosystems, it appears that the majority of these microbial species cannot be cultured when
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removed from the niches in their host animals (Moran, 2007). The fragile composition of the gut
microbiota can be affected by various factors such as age, diet, environment, stress and medication
(Choct, 2009; Maslowski and Mackay, 2010; Bäckhed, 2011). Dietary ingredients have a profound
effect on the composition of the gut microflora, which in turn, regulates the physiology of all
animals (Fraune and Bosch, 2010). Hence, nutritional components of the diet are of critical
importance for both the host and its intestinal microbiota, which in turn, will determine the balance
between health and disease. Colonization of different microflora in the mucosal surface of
metazoans initiates at birth, and is tracked by progressive assembly of a complex and dynamic
microbial society maintaining a perfect homeostasis (Martin et al., 2010; Di Mauro et al., 2013).
Perhaps, one of the most intriguing aspects of a balance microbiome is its impact on the
innate and adaptive immune system (Hammes and Hertel, 2002; Parvez et al., 2006; Parracho et
al., 2007). In this context, a short window of time during birth exists that enables the colonization
of symbiotic bacteria to all mucosal surfaces, which may modify the future immune phenotype of
the host (Martin, 2012; Almqvist et al., 2012; Hansen et al., 2013). Delayed microbial colonization
of the gut mucosa, the largest immune organ of the body, could cause significant changes in the
immune system possibly having long term impacts on systemic immunity (Thavagnanam et al.,
2008; Martin et al., 2010; Guibas et al., 2013). Animal and human studies have provided evidence
that specific bacterial strains are capable of stimulating multiple aspects of innate immunity
(Alvarez-Olmos and Oberhelman, 2001; Reveneau et al., 2002; Farnell et al., 2006; Feng and Elson,
2010; Maslowski and Mackay, 2010; Salzman, 2011; Jounai et al., 2012) and humoral immunity
(Arvola et al., 1999; Joint, 2001; Kalliomaki et al., 2001; Ouwehand et al., 2002; Parvez et al.,
2006). Fascinatingly, through a process of “cross talk” with the mucosal immune system, the
microbiota negotiates mutual growth, survival, and inflammatory control of the intestinal
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ecosystem (Salzman, 2011), having remarkable effects on gut permeability (Lyte, 2011; Yu et al.,
2012b; Howarth and Wang, 2013). In this regard, recent studies published in our laboratory suggest
that early infection with

Salmonella Enteritidis (SE) induce severe inflammation, increase

intestinal permeability and mucosal barrier dysfunction that were associated with increase organ
invasion and intestinal colonization of SE. However these adverse effects were prevented by the
administration of a commercial lactic acid base probiotic in chickens (Prado-Rebolledo et al.,
2017). Hence, the objectives of the present study were to characterize different lactic acid bacteria
(LAB) probiotic candidates based on multiple microbiological properties, and evaluate the effect
of these selected LAB isolates on epithelial permeability in vitro, and in vivo Salmonella
Typhimurium (ST) cecal colonization in neonatal turkey poults.
5.3 Material and Methods

5.3.1 Isolation and Selection of Bacterial Candidates
A total of 90 probiotic candidates were isolated from 34 week-old broiler chickens. Briefly,
cecal epithelium, cecal content, and ileal epithelium were separated, homogenized, serially diluted
with 0.9 % sterile saline solution and plated on de Man Rogosa Sharpe (MRS) agar plates (Catalog
no. 288110, Becton Dickinson and Co., Sparks, MD 21152 USA). Single colonies were obtained,
identified with a number and evaluated for in vitro antimicrobial activity against enteropathogenic
bacteria. Three candidates were identified as 128, 131 and CE11_2 and selected because all
showed the highest zone of inhibition against different enteropathogens. These isolates were
identified by 16S rRNA sequence analyses (Microbial ID Inc., Newark, DE 19713, USA) and were
further evaluated for multiple microbiological properties as probiotic candidates, as well as their
in vitro effect on intestinal epithelial permeability and in vivo ability to reduce ST intestinal
colonization in turkey poults as described below.
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5.3.2 Candidate Probiotic Culture Conditions, Morphology Characterization, and Biochemical
Tests
Bacterial strains were maintained as frozen stocks at -80°C in 50% glycerol aliquots.
Selected candidates were routinely cultured at 37°C under microaerophilic conditions in MRS
broth. Each isolate was passed three times every 8 h in MRS broth. Then, bacteria were washed
three times, resuspended in sterile 1 x PBS and adjusted an optical density (OD600) of 0.8-0.9. Each
isolate was tested for Gram stain affinity, catalase and oxidase production (Lanyi, 1988).

5.3.3 Evaluation of Probiotic Candidates to Different Biochemical Conditions: pH, Temperature,
and Sodium Chloride Concentration

A basal MRS medium was used in these series of in vitro studies. An overnight culture of
each isolate was used as the inoculum whereby the cells were centrifuged and re-suspended in 0.9 %
sterile saline. The suspension (100 μl) was inoculated into 10 mL of MRS broth. Two incubation
time points (2 and 4 h) were evaluated for each of the variables (pH, temperature, and sodium
chloride concentration). The rationale for these two points was mainly based on digesta feed
passage time through the gastrointestinal tract of poultry. The temperatures tested were 15 and
45°C, and the concentrations of sodium chloride (NaCl) tested were 3.5 and 6.5 % (w/v).
Additionally, the LAB candidates were tested for survivability under two different pH conditions
(2.0 and 3.0). The tubes were incubated with reciprocal shaking, at the specific test temperatures
or at 37°C for the tests of pH and concentrations of NaCl. At each time point evaluated, each
sample was struck onto MRS agar for presence or absence of growth, to confirm livability of the
strains. The turbidity of each tube was also noted as an indication of growth or no-growth. Each
treatment was tested by triplicate.
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5.3.4 Bile Salts Tolerance
The method of Gilliland et al. (1984), with some modifications, was used to determine bile
salt tolerance. MRS broth containing 0 %, 0.4 %, 0.5 %, or 0.6 % of bile salts No. 3 (Catalog no.
213010, Becton Dickinson and Co., Sparks, MD 21152 USA) was inoculated with 107 cfu/mL of
each probiotic strain, after being centrifuged at 3000 g for 15 minutes and washed three times from
their overnight growth cultures. Samples were incubated for 24 h at 37°C with shaking at 100 rpm.
Growth in control (no bile salts) and test cultures was evaluated at 2, 4, and 24 h by streaking
samples onto MRS agar for presence or absence of growth.

5.3.5 In vitro Assessment of Antimicrobial Activity against Enteropathogenic Bacteria
The LAB isolates were screened for in vitro antimicrobial activity against Salmonella
enterica serovar Enteritidis (SE), Salmonella enterica serovar Typhimurium (ST), and
Campylobacter jejuni (CJ). Ten microliters of each isolate were placed in the center of MRS plates.
After 24 h of incubation at 37°C, the plated samples were overlaid with tryptic soy agar (TSA,
catalog no. 211822, Becton Dickinson, Sparks, MD) containing 106 cfu/mL of SE or ST. After 24
h of incubation at 37°C, plates were evaluated and those colonies that produced zones of inhibition
were selected. A similar overlay method as described above was used for CJ, where 106 cfu/mL of
CJ was inoculated in TSA containing 0.2 g of sodium thioglycolate as a reducing agent, and
overlaid over the solid agar. Plates were incubated in a microaerophilic environment for 48 h at
42°C. Colonies that produced zones of inhibition were selected by triplicate.

5.3.6 Cell Culture of Epithelial Caco-2 cells
Epithelial Caco-2 cells, obtained from the American Type Culture Collection, were grown
in high-glucose Dulbecco’s modified Eagle’s media (DMEM). Medium was supplemented with
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10% Fetal Bovine Serum, 2% L-glutamine and 1% penicillin/streptomycin. Caco-2 cells cultivated
in permeable filter inserts were washed twice with Hank’s Balanced Salt Solution and maintained
under a humidified atmosphere of 5% CO2 at 37°C.

5.3.7 Evaluation of Lactic Acid Bacteria Probiotic Candidates on Transepithelial Electrical
Resistance of Stressed Caco-2 Cells

A Transepithelial Electrical Resistance (TEER) assay was performed in epithelial Caco-2
cell cultures stressed by exposure to 5mM of hydrogen peroxide (H2O2) during different time
points to induce an experimental inflammatory process. Briefly, cells were seeded on fibronectin
coated polycarbonate membrane inserts in transwell plates (0.4μm pore size, Corning #3413) at a
density of 2 × 105 cells/ml. Culture media were replaced every two days until a confluent
monolayer was obtained. A Millicell-ERS voltohmmeter (Millipore, Bedford, MA) was used to
measure the TEER. After two weeks of cell culture when TEER measurements reached above
1,000 ohm, Caco-2 cell monolayers were used to evaluate the effect of the probiotic on cell
permeability. Briefly, Caco-2 cells cultivated in permeable filter inserts were washed twice with
Hank’s Balanced Salt Solution. The monolayer on the apical side of inserts were treated with
probiotic candidates mixed in DMEM at an incubation ratio [Multiplicity of Infection] of 10:1
bacteria : epithelial cell ratios. TEER was measured at different time points: before probiotic
treatment of monolayers, and 3 or 5 h after treatment with H2O2. TEER was expressed as
percentage of resistance, normalized to initial value. Each probiotic candidate strain was
replicated in 4 transwells. In the non-treated group, the transwells were not incubated with any
probiotic strains, but treated with 5mM H2O2. A blank group was also included. In this group,
Caco-2 cell cultures were not incubated with any probiotics and not treated with H2O2.
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5.3.8 Salmonella Culture for In Vivo Trials
The enteropathogen ST which served as a challenge pathogen was obtained from the
USDA National Veterinary Services Laboratory (Ames, Iowa). This isolate was selected for
resistance to novobiocin (NO) and naladixic acid (NA). For the present studies, 100µL of ST from
a frozen aliquot were added to 10 mL of Tryptic Soy broth (TSB, Catalog no. 211822, Becton
Dickinson, Sparks, MD) and incubated at 37°C for 8 h. This was followed by two passages every
8 h into fresh TSB for a total of 24 h, to ensure log phase growth. Post incubation, bacterial cells
were washed 3 times in sterile 0.9% saline by centrifugation (1,864 × g, 4°C, 15 min), quantified
with a spectrophotometer (Spectronic 20D+, Spectronic Instruments Thermo Scientific) at 625nm
using an established concentration curve, and diluted in sterile 0.9% saline as per required
concentrations (cfu/mL) for the trials. Concentrations of ST were also determined retrospectively
by serial dilution and further plating on BGA with NO (25µg/mL, catalog no. N-1628, Sigma) and
NA (20µg/mL, catalog no. N-4382, Sigma) for enumeration of actual cfu/mL used for challenge,
as reported below.

5.3.9 Experimental Animals

Day-of-hatch, turkey poults were obtained from a local hatchery (Gentry, AR, USA) and
placed in isolators with controlled age-appropriate environment. Poults were provided ad libitum
access to water and a balanced unmedicated corn-soybean diet meeting the nutrition requirements
of poultry recommended by the NRC (1994). All animal handling procedures were in compliance
with Institutional Animal Care and Use Committee at the University of Arkansas. Twelve poults
for each trial were humanely killed and sampled upon arrival at the laboratory. Whole ceca-cecal
tonsils (CCT), liver/spleen, and trachea were aseptically removed from these neonate poults,
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incised and cultured in 10 ml tetrathionate enrichment broth (Catalog no. 210420, Becton
Dickinson, Sparks, MD) and incubated overnight at 37°C. The samples were confirmed negative
for Salmonella spp. by plating onto selective Brilliant Green Agar (BGA, Catalog no. 70134,
Sigma) with NO (25µg/mL) and NA (20µg/mL).

5.3.10 Experimental Design

Two independent trials were conducted. In each trial, sixty neonatal turkey poults were
randomly assigned to one of five groups (n=12/group); 1) Control ST challenged; 2) ST challenged
plus probiotic candidate 128; 3) ST challenged plus probiotic candidate 131; 4) ST challenged plus
probiotic candidate CE11_2; 5) ST challenged plus batch probiotic culture. The challenge with ST
was administered to all groups of poults on arrival at the laboratory by oral gavage (4 ×104 cfu/0.25
mL/bird) using an animal feeding needle. Each candidate probiotic strain was grown individually
or combined as a batch culture (1:1:1) on MRS broth. At 1 h post challenge, probiotic candidates
were administered to poults by oral gavage (4 x 106 cfu/0.25 mL/bird). In each trial, at 24 h post
ST challenge, all poults in all groups were euthanized by CO2 asphyxiation. In both trials, CCT
were aseptically collected for ST recovery as explained below.

5.3.11 Recovery of Salmonella

Briefly, whole CCT were aseptically removed, collected in sterile bags, weighed,
homogenized, and serially diluted with sterile 0.9% saline (1:4 wt/vol). Tenfold dilutions of each
sample, according to groups, were subsequently made in a sterile 96 well flat bottom plate and the
diluted samples were plated on BGA with NO and NA, incubated at 37°C for 24 h to enumerate
total Salmonella cfu.
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5.3.12 Data and Statistical Analysis

Epithelial permeability TEER values as well as Log10 cfu/g of ST in cecal contents were
subjected to ANOVA as a completely randomized design, using the GLM procedure of SAS (SAS
Institute, 2002). Significant differences among the means were determined by Duncan’s multiplerange test at P < 0.05.
5.4 Results
Table 1 shows the results of the morphological characteristics and identification of LAB
probiotic candidates evaluated. In the present study, all three selected LAB candidate strains were
classified as Gram-positive with a negative catalase and oxidase reaction. Candidates 128 and 131
showed coccus morphology and were identified by 16S RNA sequencing as Enterococcus faecium.
Candidate CE11_2 showed a cluster of cocci-shaped morphology and was identified as
Pediococcus parvulus (Table 1). All candidates evaluated were able to grow when cultured at
0.4 %, 0.5 %, and 0.6 % bile salts concentration at 2, 4, and 24 h of incubation (data not shown).
The results of the tolerance of LAB bacteria probiotic candidates to different pH, temperature and
NaCl concentrations are summarized in Table 2. Candidate CE11_2 did not survive an incubation
period of 2 or 4 h at pH 2.0. Candidates 128 and 131 did survive at pH 2.0 for only 2 h. However,
all strains were tolerant after 2 and 4 h of incubation at a pH of 3.0, temperatures of 15 and 45°C,
or high concentration (6.5 %) of NaCl (Table 2). Table 3 shows the results of the in vitro
assessment of antimicrobial activity of LAB probiotic candidates against enteropathogenic
bacteria. All three lactic acid isolates exhibited in vitro antimicrobial activity against SE, ST, and
CJ (Table 3). The results of the in vitro effect of LAB probiotic candidates on TEER of Caco-2
cells stressed at 3 and 5 hours with H2O2 are summarized in Table 4. All three-candidate probiotics
significantly increased TEER following 3 h of H2O2 administration when compared with negative
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control or blank cells. However, following 5 h of H2O2 stress, only those Caco-2 cells treated with
the CE11_2 strain, showed a significant increase of TEER when compared with Caco-2 cells
without probiotic (Table 4). Table 5 shows the results of the evaluation of LAB probiotic
candidates on ST cecal colonization in turkey poults. The combination of all three bacteria
candidates as a batch culture (1:1:1), significantly reduced cecal colonization of ST when
compared with non-treated control poults or the groups that received a single candidate strain
(Table 5).
5.5 Discussion
Salmonellosis remains one of the most comprehensive foodborne diseases that can be
transmitted to humans through animal and plant products (Hernández-Reyes and Schikora, 2013)
(Zheng et al., 2013), however, in recent years, several studies have demonstrated the use of
probiotics as alternative tool to antibiotic growth promoters in poultry, preventing or controlling
the presentation of Salmonella outbreaks (Hammes and Hertel, 2002; Tellez et al., 2012).
Furthermore, probiotic bacteria have been shown to regulate production of pro-inflammatory and
anti-inflammatory cytokines (Lyte, 2011), exert anti-oxidant properties (Howarth and Wang,
2013), enhance barrier integrity (Yu et al., 2012a,b), as well as innate (Vanderpool et al., 2008;
Molinaro et al., 2012) and humoral immunity (Howarth and Wang, 2013). In the present study, the
3 probiotic candidates showed good tolerance to conditions present in the intestinal tract and also
exhibited in vitro antimicrobial activity against three important poultry enteropathogens (SE, ST
and CJ). Moreover, the combination of all three bacteria candidates as a batch culture (1:1:1),
significantly reduced the cecal colonization of ST when compared with control poults with no
probiotic in two independent trials. On the other hand, intestinal epithelial cells are not only
responsible for digestion, secretion and absorption of nutrients, but act as a physical barrier
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separating external environmental agents from the internal host environment (Salzman, 2011). In
these epithelial cells, tight junctions (TJ) act as intercellular cement regulating the permeability
and dissemination of microorganisms and antigens from the intestinal lumen to the systemic
circulation (Ulluwishewa et al., 2011). Endotoxins from Salmonella spp. have been shown to
activate aldose reductase (AR) and the nuclear factor kappa B (NF-κB), iducing the expression of
several inflammatory cytokines that are responsible disruption of TJ complex proteins and loss of
barrier function (Ozinsky et al., 2000; Liao et al., 2008; Steed et al., 2010; Overman et al., 2012;
Pastel et al., 2012). Interestingly, microarray analysis with probiotic cultures in broiler chickens
challenged with SE showed a significant reduction in intestinal gene expression associated with
the NF-κB complex and AR (Higgins et al., 2011). In the present study, the increase TEER
following 3 hours of H2O2 administration by the probiotic candidates on Caco-2 cells are in
agreement with previous published studies suggesting that these candidates suppressed the
oxidant-induced intestinal permeability, and improve intestinal barrier function (Johansson et al.,
2010; Yu et al., 2012a; Nava and Vidal, 2016). TEER measures the flux of all ions across the
epithelial lining, and recently it has been demonstrated that probiotics increase gene expression of
TJ proteins (Alvarez et al., 2016). Increased TEER can be used as an indicator of the integrity of
TJ proteins, hence reducing paracellular permeability. Metchnikoff (1907) founded the research
field of beneficial microorganisms for animals and humans (probiotics), aimed at modulating the
intestinal microflora. Currently, new molecular techniques are helping us to understand how the
anti-inflammatory, cell integrity and anti-oxidant properties of probiotics can improve gut and
barrier integrity. Given the recent international legislation and domestic consumer pressures to
withdraw growth-promoting antibiotics and limit antibiotics available for treatment of bacterial
infections, probiotics may offer alternative options. Together, the results of the present
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investigation show critical and important characteristics of LAB to be evaluated when selecting
strains to be used as probiotics for poultry. Furthermore, the selected LAB probiotic candidates
enhanced in vitro intestinal epithelial permeability and reduced ST intestinal colonization in
neonatal turkey poults. The supplementation of these strains on growth performance of turkeys is
currently being evaluated.
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5.8 Tables
Table 1. Morphological characteristics and identification of lactic acid bacteria probiotic
candidates1

1

Symbols: (+), positive; (-), negative.
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Table 2. Tolerance of lactic acid bacteria probiotic candidates to different pH, temperature and
NaCl concentrations1
pH2
pH3
15ºC
45ºC
3.5% NaCl
6.5% NaCl
LAB ID

1

2h 4h

2h 4h

2h 4h

2h 4h

2h 4h

2h 4h

128

+

-

+

+

+

+

+

+

+

+

+

+

131

+

-

+

+

+

+

+

+

+

+

+

+

CE11_2

-

-

+

+

+

+

+

+

+

+

+

+

Symbols: (+), tolerant; (-), not tolerant.
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Table 3. In vitro assessment of antimicrobial activity of lactic acid bacteria probiotic candidates
against enteropathogenic bacteria1
ID
Salmonella
Salmonella
Campylobacter
Enteritidis
Typhimurium
jejuni
128
0.7 cm
1.15 cm
1.1 cm
131

1.2 cm

1.1 cm

1.0 cm

CE11_2

1.0 cm

0.975 cm

0.8 cm

1

Represents the diameter of the zone of inhibition observed at 24 h of incubation. All lactic acid
bacteria candidates were tested by triplicate
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Table 4. In vitro effect of lactic acid bacteria probiotic candidates on transepithelial electrical
resistance (TEER) of Caco-2 cells stressed at 3 and 5 hours with hydrogen peroxide (H2O2)1
TEER
TEER
LAB ID
Treated with H2O2 for 3 h
Treated with H2O2 for 5 h
128

96.27 ±4.13 a

32.48 ±2.15 d

131

98.79 ±2.01 a

32.64 ±0.84 d

CE11_2

103.19 ±0.78 a

49.80 ±1.46 b

Non-treated

81.90 ±1.43 b

41.55 ±0.90 c

Blank

84.64 ±1.21 b

119.66 ±2.59 a

1

The initial in vitro TEER determination of each transwell was normalized as 100% when
analyzing these data. Each strain was replicated in 4 transwells. In the negative control, the
transwells were not incubated with any probiotic strains, but treated with 5 mM H2O2, while blank
wells were not incubated with any probiotics nor treated with H2O2.
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Table 5. Evaluation of lactic acid bacteria probiotic candidates on Salmonella Typhimurium
cecal colonization in turkey poults1
Log10 S. Typhimurium /g
Log10 S. Typhimurium /g
Treatment
Caeca-cecal content
Caeca-cecal content
Trial 1
Trial 2
a
Saline
6.43 ± 0.14
6.51 ± 0.31 a
128

6.09 ± 0.20 ab

5.77 ± 0.22 ab

131

6.89 ± 0.33 a

5.47 ± 0.18 b

CE11_2

6.27 ± 0.30 ab

5.78 ± 0.25 ab

Batch2

5.20 ± 0.35 b

5.54 ± 0.24 b

1

Ceca-cecal tonsils were cultured to enumerate Log10 cfu of ST/g of cecal content, and the data are
expressed as mean ±standard error of the mean.
2
Combination on an equal ratio of each of the lactic acid bacteria candidates (1:1:1).
a–b
Different superscripts within columns indicate significant differences P < 0.05; n=12
turkeys/group
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CONCLUSION
In this dissertation, the approaches for controlling Salmonella infection were determined and

estimated as the effective methods. Salmonella-based recombinant vaccines have been shown to
be effective for controlling the challenges from cross-serotype infection of Salmonella Heidelberg.
The number of Salmonella colonization in the ceca of chicken was decreased by comparing with
the control group. The other approach for controlling Salmonella infection is isolation of functional
probiotics, which showed promising result in decreasing gut permeability and reducing pathogen
colonization in the chicken gut. We developed a novel approach for researching Salmonella
transmission within the chicken flock by inserting 6 random nucleotides into the functional neutral
regions in the genome of Salmonella enteritidis, which was named as Salmonella barcode-tagged
isogenic strains. This approach has been estimated as the effective and novel method to analyze
Salmonella transmission mechanism. The proof of concept has been substantiated by three chicken
experiments and providing valuable data to study Salmonella transmission within the chicken flock.
The project of researching the competitive exclusion theory has also been substantiated by using
the constructed Salmonella barcode-tagged isogenic strains. It provides a profound insight for the
future research in Salmonella population transmission.
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